# EDGAR Filing Document

**Accession Number:** 0001896036
**File Stem:** 0001104659-25-083280
**Filing Date:** 2025-8
**Character Count:** 188754
**Document Hash:** 9ac9012fb83f192f3623da759ecaaedf
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-083280.hdr.sgml**: 20250827

**ACCESSION NUMBER**: 0001104659-25-083280

**CONFORMED SUBMISSION TYPE**: N-CSRS

**PUBLIC DOCUMENT COUNT**: 8

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250827

**DATE AS OF CHANGE**: 20250827

**EFFECTIVENESS DATE**: 20250827

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eagle Point Institutional Income Fund
- **CENTRAL INDEX KEY:** 0001896036

**ORGANIZATION NAME:**
- **EIN:** 873667759
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-CSRS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23758
- **FILM NUMBER:** 251259557

**BUSINESS ADDRESS:**
- **STREET 1:** C/O EAGLE POINT CREDIT MANAGEMENT LLC
- **STREET 2:** 600 STEAMBOAT ROAD, SUITE 202
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203.340.8500

**MAIL ADDRESS:**
- **STREET 1:** C/O EAGLE POINT CREDIT MANAGEMENT LLC
- **STREET 2:** 600 STEAMBOAT ROAD, SUITE 202
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM N-CSR**

**CERTIFIED SHAREHOLDER REPORT OF REGISTERED**

**MANAGEMENT INVESTMENT COMPANIES**

Investment Company Act File Number: **811-23758**

**Eagle Point Institutional Income Fund**

(Exact name of registrant as specified in charter)

**600 Steamboat Road, Suite 202**

**Greenwich, CT 06830**

(Address of principal executive offices) (Zip code)

**Thomas P. Majewski**

**c/o Eagle Point Institutional Income Fund**

**600 Steamboat Road, Suite 202**

**Greenwich, CT 06830**

(Name and address of agent for service)

***Copies to***

**Thomas J. Friedmann**

**Philip Hinkle<br> Dechert LLP<br> One International Place, 40<sup>th</sup> Floor**

**100 Oliver Street**

**Boston, MA 02110<br> (617) 728-7120**

Registrant's telephone number, including area code: **(203) 340-8500**

Date of fiscal year end: **December 31**

Date of reporting period: **June 30, 2025**

**Item 1. Report to Stockholders**

The Semiannual Report to shareholders of the registrant for the six months ending June 30, 2025, is filed herewith.

![[MISSING IMAGE: cv_ofc-4c.jpg]](cv_ofc-4c.jpg)

------

![[MISSING IMAGE: bn_eaglepoint-4clr.jpg]](bn_eaglepoint-4clr.jpg)

Eagle Point Institutional Income Fund <br>Semiannual Report — June 30, 2025

**Table of Contents**

---

| | |
|:---|:---|
| [Letter to Shareholders and Management Discussion of Fund Performance](#tLTSA)  | [2](#tLTSA) |
| [Important Information about this Report and Eagle Point Institutional Income Fund](#tIIAT)  | [9](#tIIAT) |
| [Summary of Certain Unaudited Portfolio Characteristics](#tSOCU)  | [10](#tSOCU) |
| [Consolidated Financial Statements for the Six Months Ended June 30, 2025 (Unaudited)](#tCFSF)  | [12](#tCFSF) |
| [Distribution Reinvestment Plan](#tDRP)  | [44](#tDRP) |
| [Additional Information](#tADIN)  | [45](#tADIN) |

---

1 <br>

------

![[MISSING IMAGE: bn_eaglepointtext-4clr.jpg]](bn_eaglepointtext-4clr.jpg)

Letter to Shareholders and Management Discussion of Fund Performance

Dear Fellow Shareholders:

We are pleased to provide you with the enclosed report of Eagle Point Institutional Income Fund ("we," "us," "our" or the "Fund") for the six months ended June 30, 2025.

The Fund is a closed-end management investment company registered under the Investment Company Act of 1940, as amended (the "1940 Act") and is advised by Eagle Point Credit Management LLC (the "Adviser"). The Fund is organized as a Delaware statutory trust and offers its common shares of beneficial interest ("Shares") to investors on a continuous basis at the Fund's net asset value ("NAV") per share plus any applicable sales load. The Fund's primary investment objective is to generate high current income, with a secondary objective to generate capital gains. We seek to achieve these objectives by investing primarily in equity and junior debt tranches of collateralized loan obligations ("CLOs"). We may also invest in other securities or instruments that are related investments or that are consistent with our investment objectives.

Our Adviser has significant expertise in CLO investing, with 78 years of combined CLO industry experience across its senior investment team. As of July 31, 2025, the Adviser managed $13 billion<sup>1</sup> on behalf of principally institutional clients. The Adviser formed the Fund in 2022 to provide retail investors with access to institutional credit investment strategies in a continuously offered, SEC-registered and non-traded format.

In the first half of 2025, the Fund delivered consistent income, while capitalizing on the dislocation to invest in attractive discounted CLO equity opportunities. Some highlights include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ▪ The Fund paid $0.498 per share in distributions during the first six months of 2025, resulting in an annualized distribution rate of 11.6%. June marked our 36<sup>th</sup> consecutive monthly distribution to shareholders.<sup>2</sup>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ▪ For the first half of 2025 due to the Adviser's structuring expertise, the Fund's CLO portfolio generated steady and robust cash flows, annualizing to a 32.1%<sup>3</sup> cash-on-cash return and provided the Fund with valuable dry powder to deploy into attractive new investments during the dip caused by the tariff uncertainty.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ▪ As of June 30, 2025, the Fund's total assets exceeded $213 million, inclusive of available borrowings under a revolving credit facility. The Fund's growth has been supported by consistent net capital inflows through sales of the Fund's shares and reinvestment of distributions, totaling $32 million for the first half of 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ▪ We completed a private placement of preferred stock (the "Series B Term Preferred Shares"), resulting in $29 million of net proceeds, which we believe provides attractive, long-term capital for the Fund and will lead to an increase in net investment income.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ▪ During the first half of 2025, we deployed $58 million into new investments, including CLO equity with a weighted average effective yield ("WAEY") of 17.6% at the time of purchase. We expect these discounted purchases to be highly accretive to the Fund's earnings power over time.

#### Past performance is not indicative of, or a guarantee of, future performance.

#### Please see page 7 for endnotes.
2 <br>

------

![[MISSING IMAGE: bn_eaglepoint-4clr.jpg]](bn_eaglepoint-4clr.jpg)

The Fund's investment portfolio as of June 30, 2025 consisted of 103 unique CLO investments. Importantly, essentially all of the Fund's investments were also investments made by other institutional funds and accounts managed by the Adviser. To the extent that the Fund (along with other funds and accounts managed by the Adviser) owns a majority position in the CLO equity tranche, our Adviser has the ability to exercise certain majority rights over the vehicle (such as the ability to call the CLO after the non-call period, to refinance and/or reset CLO debt tranches after the non-call period and to influence potential amendments to the governing documents of the CLO) that may reduce the risk in these investments and/or enhance the Fund's economics.

As the majority CLO equity owner of many of our CLO investments, Eagle Point capitalized on our ability to proactively reset and refinance CLO liabilities. In the first half of 2025, of the resets completed, each reset created a new 5-year reinvestment period for those CLOs and reduced the weighted average CLO debt financing cost by 42 bps in those CLOs. The refinancings resulted in weighted savings of 45 bps to the Fund across the refinanced CLOs. Looking ahead, we have a healthy pipeline of resets and refinancings that are slated for the second half of 2025 and expect our actions to unlock further upside within our CLO equity portfolio.

Our proactive portfolio management approach enables us to sustain a healthy weighted average remaining reinvestment period ("WARRP") of the Fund's CLO equity portfolio of 3.8 years as of June 30, 2025. We believe this extended WARRP, roughly 65% longer than the broader market average, offers protection from loan price volatility and enables our CLOs to capitalize on periods of market dislocation, as we observed in the first half of 2025.

We also want to highlight the Fund's dividend reinvestment plan for common shareholders. This plan allows shareholders to elect to have their distributions reinvested into new shares at a 5% discount to NAV per share. We encourage all shareholders to carefully review the terms of the plan. See "***Dividend Reinvestment Plan***" in the enclosed report.

Market Overview<sup>4</sup>

Loan Market

For the first half of 2025, loan performance temporarily faced pressure, consistent with broader market volatility, but largely recovered by the end of June. Average leveraged loan prices finished the first half of 2025 at 96.48, a modest increase from 96.37 at the beginning of the year. The S&P UBS Leveraged Loan Index,<sup>5</sup> which is a broad index followed by many tracking the corporate loan market, generated a non-annualized total return of 3.0% in the first half of 2025.

Gross loan issuance totaled over $441 billion for the first half of 2025, compared to $703 billion for the first half of 2024. However, net new loan issuance for the year has been more measured at just $102 billion due to substantial refinancings, repricings and repayments. Total institutional loans outstanding stood at $1.5 trillion as of June 30, 2025.

Credit quality remains relatively strong, with the trailing 12-month par-weighted default rate at 1.11% at the end of June, up modestly from 0.91% at year-end 2024, but well below the long-term

#### Past performance is not indicative of, or a guarantee of, future performance.

#### Please see page 7 for endnotes.
3 <br>

------

![[MISSING IMAGE: bn_eaglepoint-4clr.jpg]](bn_eaglepoint-4clr.jpg)

average of 2.57%.<sup>6</sup> While many CLO investors focus on default rates, we believe the market does not give enough consideration to loan repayment rates and the reinvestment periods within CLOs, which allows CLOs to purchase loans at a discount in choppier markets.

Importantly, with over $118 billion of broadly syndicated loans repaying at par in the first half of 2025, the 12-month trailing loan repayment rate decreased to 20.9% as of June 30, 2025, down from 27.9% at the end of 2024. With 1.7% of the loan market set to mature prior to 2027, the "maturity wall" continues to be pushed out and we do not view loan maturities as a meaningful risk.

CLO Market

The CLO market saw $100 billion of new gross CLO issuance in the first half of 2025, but due to repayments at par of many CLO securities, net issuance remained much more measured at $48 billion.

CLO reset and refinancing activity remained robust, driven by strong CLO debt investor demand and attractive economics, which typically act as a tailwind to CLO equity valuations. The first half of 2025 saw $108 billion of resets and $49 billion of refinancings.

In the first half of 2025, there were $34 billion of CLO AAA paydowns, and research reports estimated another $17 billion of CLO AAA paydowns in July. We believe that absent unexpected volatility, tightening pressure on CLO AAA spreads will likely remain and encourage more CLO reset and refinancing activity. Our CLO equity portfolio's weighted average CLO AAA financing cost is currently 142 bps over the Secured Overnight Financing Rate ("SOFR"), but CLO AAAs are currently pricing around 125 bps over SOFR in the primary market today, implying potential upside for our portfolio.

The underlying fundamentals of CLO portfolios remain strong. The median market-wide CCC-rated loan exposure for US CLOs was 6.5%, with average overcollateralization cushions of 3.5% on June 30, 2025. Our Fund's portfolio compares favorably, with the CCC-rated loan exposure at 4.3% and the average overcollateralization cushion of 4.6%, as a result of our conservative and methodical approach to portfolio construction.

We believe the CLO equity market is poised for strong returns as we move through the back half of the year. Historically, CLO equity performance trails leveraged loans which in turn trails stock performance. As previously referenced, leveraged loan prices have now mostly recovered since peak volatility earlier this year; however, CLO equity has yet to fully benefit from this recovery. This suggests potential for further upside to CLO equity investors in our opinion.

Additionally, AAA CLO spreads have not fully retraced despite the recovery in underlying loans. Prior to early April, these spreads were as tight as 110 bps over SOFR; today they hover around 125 bps over SOFR. This dynamic is notable as it makes new issue arbitrage for newly created CLO equity less compelling, absent special circumstances. That said, we are actively maintaining a robust pipeline of loan accumulation facilities to remain prepared when opportunities for deployment into new issue CLOs arise.

#### Past performance is not indicative of, or a guarantee of, future performance.

#### Please see page 7 for endnotes.
4 <br>

------

![[MISSING IMAGE: bn_eaglepoint-4clr.jpg]](bn_eaglepoint-4clr.jpg)

We expect several factors will be working in favor of our CLO equity portfolio through year-end, including a catch-up in broader CLO equity valuations, the optionality realized from strategic resets and refinancings and the accretive impact of discounted loan purchases made in April and May now rallying. Against that, we are mindful of the potential for loan spread compression should markets remain strong.

Moving forward, we continue to maintain a robust pipeline of new issue, secondary opportunities, resets and refinancings. Provided CLO debt spreads remain stable or tighten further, we are well-positioned to actively pursue these opportunities throughout the remainder of the year. These developments, along with broader recovery across CLO equity, are poised to reduce CLO financing costs, ultimately boosting CLO equity cash flows and positively impacting our net investment income.

We remain excited about the investment opportunities within the CLO market and believe there is significant value within the equity portion of the capital structure. Our portfolio is well positioned for the remainder of 2025, and we are confident about continuing to deliver value to our shareholders.

Additional Information

In addition to the Fund's regulatory requirement to file certain portfolio information with the SEC (as described further in the enclosed report), the Fund makes certain additional financial information available to investors via its website (www.EPIIF.com), press releases and other public disclosures.

About Our Adviser

Eagle Point Credit Management LLC is an investment manager focused on private credit strategies in inefficient markets, including Portfolio Debt Securities, Regulatory Capital Relief transactions, Strategic Credit investments and CLO securities. As of July 31, 2025, our Adviser and its affiliates had $13 billion of assets under management (inclusive of undrawn capital commitments).<sup>1</sup>

Subsequent Developments

Pursuant to the Fund's continuous offering, the Fund issued shares for total net proceeds of $6 million during the month of July 2025.

For the month of July 2025, the Fund declared and paid a distribution in the amount of $0.083 per share, representing an 11.6% annualized distribution rate<sup>2</sup> based on the Fund's NAV per share of $8.55 as of June 30, 2025.

\* \* \* \*

#### Past performance is not indicative of, or a guarantee of, future performance.

#### Please see page 7 for endnotes.
5 <br>

------

![[MISSING IMAGE: bn_eaglepoint-4clr.jpg]](bn_eaglepoint-4clr.jpg)

Management remains keenly focused on continuing to create value for our shareholders. We appreciate the trust and confidence our fellow shareholders have placed in the Fund**.** 

Thomas Majewski <br>Chairman and Chief Executive Officer

 *This letter is intended to assist shareholders in understanding the Fund's performance during the six months ended June 30, 2025. The views and opinions in this letter were current as of July 31, 2025. Statements other than those of historical facts included herein may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors. The Fund undertakes no duty to update any forward-looking statement made herein. Information contained on our website is not incorporated by reference into this shareholder letter and you should not consider information contained on our website to be part of this shareholder letter or any other report we file with the Securities and Exchange Commission.* 

#### Past performance is not indicative of, or a guarantee of, future performance.

#### Please see page 7 for endnotes.
6 <br>

------

![[MISSING IMAGE: bn_eaglepoint-4clr.jpg]](bn_eaglepoint-4clr.jpg)

Notes

<sup>1</sup> Assets under management include assets managed by Eagle Point and certain of its affiliates.

<sup>2</sup> Annualized distribution rate reflects distributions paid during the period, annualized, and divided by the period end NAV. The annualized distribution rate is not a guarantee of future returns and future performance may vary. The timing and frequency of distribution payments is not guaranteed. Such variance may be material and adverse, including the potential for full loss of principal and no distributions. In considering returns, investors should bear in mind that historical performance is not a guarantee, projection or prediction and is not indicative of future results. Actual net returns in any given year may be lower than the historical returns. Investment return and principal value of any investment will fluctuate and may be worth more or less than the amount initially invested. Distribution payments are not guaranteed. Distributions may be comprised of any combination of 1) net investment income and/or 2) net capital gain, and, if the Fund distributes an amount in excess of net investment income and net capital gains, a portion of such distribution will constitute a return of capital. A distribution comprised in whole or in part by a return of capital does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income." A return of capital distribution may reduce the amount of investable funds. The actual components of the Fund's distributions for U.S. tax reporting purposes can only be finally determined as of the end of each fiscal year of the Fund and are thereafter reported to shareholders on Form 1099-DIV.

<sup>3</sup> Cash-on-cash return represents the total amount of recurring distributions received from investments for the period over the Fund's average beginning NAV for the period, annualized. "Cash distributions" refers to the quarterly recurring cash distributions received by the Fund from its CLO equity, CLO debt and other investments and distributions from loan accumulation facilities in excess of capital invested.

<sup>4</sup> Market data and statistics summarized herein are sourced from Bloomberg, JP Morgan and Pitchbook LCD.

<sup>5</sup> The S&P UBS Leveraged Loan Index, formerly the Credit Suisse Leveraged Loan Index, tracks the investable universe of the USD-denominated leveraged loan market. You cannot invest directly in an index.

<sup>6</sup> <br>

"Par-weighted default rate" represents the rate of obligors who fail to remain current on their loans based on the par amount.

Past performance is not indicative of, or a guarantee of, future performance. <br>

7 <br>

------

Page Intentionally Left Blank

8 <br>

------

Important Information about this Report and Eagle Point Institutional Income Fund

This report is transmitted to the shareholders of Eagle Point Institutional Income Fund ("we", "us", "our" or the "Fund") and is furnished pursuant to certain regulatory requirements. This report and the information and views herein do not constitute investment advice, or a recommendation or an offer to enter into any transaction with the Fund or any of its affiliates. This report is provided for informational purposes only, does not constitute an offer to sell securities of the Fund and is not a prospectus. From time to time, the Fund may have a registration statement relating to one or more of its securities on file with the SEC. Any registration statement that has not yet been declared effective by the SEC, and any prospectus relating thereto, is not complete and may be changed. Any securities that are the subject of such a registration statement may not be sold until the registration statement filed with the SEC is effective.

The information and its contents are the property of Eagle Point Credit Management LLC (the "Adviser") and/or the Fund. Any unauthorized dissemination, copying or use of this presentation is strictly prohibited and may be in violation of law. This presentation is being provided for informational purposes only.

Investors should read the Fund's prospectus and SEC filings (which are publicly available on the EDGAR Database on the SEC website (www.sec.gov) carefully and consider their investment goals, time horizons and risk tolerance before investing in the Fund. Investors should consider the Fund's investment objectives, risks, charges and expenses carefully before investing in securities of the Fund. There is no guarantee that any of the goals, targets or objectives described in this report will be achieved.

An investment in the Fund is not appropriate for all investors. The investment program of the Fund is speculative, entails substantial risk and includes investment techniques not employed by traditional mutual funds. An investment in the Fund is not intended to be a complete investment program. **Past performance is not indicative of, or a guarantee of, future performance.** The performance and certain other portfolio information quoted herein represents information as of June 30, 2025. Nothing herein should be relied upon as a representation as to the future performance or portfolio holdings of the Fund. Investment return and principal value of an investment will fluctuate, and shares, when sold, may be worth more or less than their original cost. The Fund's performance is subject to change since the end of the period noted in this report and may be lower or higher than the performance data shown herein.

Liquidity will be provided by the Fund only through limited repurchase offers described below (if at all). An investment in the Fund is suitable only for investors who can bear the risks associated with the limited liquidity of the Shares and should be viewed as a long-term investment. The Fund's Shares will not be publicly traded and an investor should not expect to be able to sell Shares regardless of how the Fund performs.

Neither the Adviser nor the Fund provide legal, accounting or tax advice. Any statement regarding such matters is explanatory and may not be relied upon as definitive advice. Investors should consult with their legal, accounting and tax advisors regarding any potential investment. The information presented herein is as of the dates noted herein and is derived from financial and other information of the Fund, and, in certain cases, from third-party sources and reports (including reports of third-party custodians, collateralized loan obligation ("CLO") managers and trustees) that have not been independently verified by the Fund. As noted herein, certain of this information is estimated and unaudited, and therefore subject to change. We do not represent that such information is accurate or complete, and it should not be relied upon as such.

Forward-Looking Statements

This report may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this report may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Fund's filings with the SEC. The Fund undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this report.

9 <br>

------

Summary of Certain Unaudited Portfolio Characteristics

The summary of portfolio characteristics reflected below is as of June 30, 2025. The information presented below is on a look – through basis to the CLO equity held by the Fund as of June 30, 2025 (except as otherwise noted) and reflects the aggregate underlying exposure of the Fund based on the portfolios of those investments. The data is estimated and unaudited and is derived from CLO trustee reports received by the Fund relating to June 2025 and from custody statements and/or other information received from CLO collateral managers, or other third-party sources.

---

| | |
|:---|:---|
| Summary of Portfolio Investments<sup>(1)</sup>  | Summary of Portfolio Investments<sup>(1)</sup>  |
|  ![[MISSING IMAGE: pc_portfolio-4c.jpg]](pc_portfolio-4c.jpg)  | ![[MISSING IMAGE: pc_portfolio-4c.jpg]](pc_portfolio-4c.jpg)  |
| Number of CLO Securities | 103 |
| Number of Collateral Managers | 27 |
| Fair Value of CLO Equity Securities | $163M |
| Fair Value of Loan Accumulation Facility Securities | $8M |
| Fair Value of CLO Debt Securities | $12M |

---

---

| | |
|:---|:---|
| Summary of Underlying Portfolio Characteristics<sup>(2)</sup>  | Summary of Underlying Portfolio Characteristics<sup>(2)</sup>  |
| Number of Unique Underlying Loan Obligors | 1369  |
| Largest Exposure to an Individual Obligor | 0.56%  |
| Average Individual Loan Obligor Exposure | 0.07%  |
| Top 10 Loan Obligors Exposure | 4.91%  |
| Aggregate Indirect Exposure to Senior Secured Loans<sup>(3)</sup> | 97.15%  |
| Weighted Average Market Value of Loan Collateral | 97.62%  |
| Weighted Average Stated Loan Spread | 3.28%  |
| Weighted Average Loan Maturity | 4.7 years  |
| Weighted Average Remaining CLO Equity Reinvestment Period | 3.8 years  |

---

Please see footnote disclosure on Page 11. <br>

10 <br>

------

Notes

<sup>(1)</sup> <br>

The summary of portfolio investments shown is based on the estimated fair value of the underlying positions as of June 30, 2025.

<sup>(2)</sup> <br>

Information relating to the market price of underlying collateral is as of month end; however, with respect to other information shown, depending on when such information was received, the data may reflect a lag in the information reported. As such, while this information was obtained from third-party data sources, June 2025 trustee reports and similar reports, other than market price, it does not reflect actual underlying portfolio characteristics as of June 30, 2025 and this data may not be representative of current or future holdings. The weighted average remaining reinvestment period information is based on the fair value of CLO equity investments held by the Fund as of June 30, 2025.

<sup>(3)</sup> <br>

We obtain exposure in underlying senior secured loans indirectly through CLOs and related investments.

11 <br>

------

Consolidated Financial Statements for the Six Months Ended<br>June 30, 2025 (Unaudited)

---

| | |
|:---|:---|
| [Consolidated Statement of Assets and Liabilities](#fCSOA)  | [13](#fCSOA) |
| [Consolidated Schedule of Investments](#fCSOI)  | [14](#fCSOI) |
| [Consolidated Statement of Operations](#fCSOO)  | [17](#fCSOO) |
| [Consolidated Statements of Changes in Net Assets](#fCSOC)  | [18](#fCSOC) |
| [Consolidated Statement of Cash Flows](#fCSOC1)  | [19](#fCSOC1) |
| [Notes to Consolidated Financial Statements](#fNTCF)  | [20](#fNTCF) |
| [Consolidated Financial Highlights](#CFH)  | [41](#CFH) |

---

12 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Statement of Assets and Liabilities** <br>As of June 30, 2025 <br>(expressed in U.S. dollars) <br>(Unaudited)

---

| | |
|:---|:---|
| ASSETS |  |
| &nbsp;&nbsp; Investments, at fair value (cost $198,819,409)  | $183492867 |
| &nbsp;&nbsp; Interest receivable  | 4958357 |
| &nbsp;&nbsp; Deferred offering costs attributed to common shares  | 288019 |
| &nbsp;&nbsp; Prepaid expenses  | 84645 |
| &nbsp;&nbsp; Other assets  | 5303 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Assets  | 188829191 |
| LIABILITIES |  |
| &nbsp;&nbsp; 8.125% Series A Term Preferred Shares due 2029, less unamortized deferred issuance costs of $1,175,451 (1,400,000 shares outstanding <br> (Note 9))  | 33824549 |
| &nbsp;&nbsp; 8.00% Series B Term Preferred Shares due 2030, less unamortized deferred issuance costs of $819,467 (300,000 shares outstanding (Note 9))  | 29180533 |
| &nbsp;&nbsp; Due to custodian  | 1591112 |
| &nbsp;&nbsp; Management fee payable  | 770601 |
| &nbsp;&nbsp; Incentive fee payable  | 563210 |
| &nbsp;&nbsp; Professional fees payable  | 324601 |
| &nbsp;&nbsp; Interest payable  | 156181 |
| &nbsp;&nbsp; Administration fees payable  | 92600 |
| &nbsp;&nbsp; Transfer agent fees payable  | 70256 |
| &nbsp;&nbsp; Trustees' fees payable  | 53250 |
| &nbsp;&nbsp; Other expenses payable  | 26342 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Liabilities  | 66653234 |
| COMMITMENTS AND CONTINGENCIES (Note 6) |  |
| NET ASSETS applicable to common shares, unlimited shares authorized, 14,295,539 shares issued and outstanding  | $122175957 |
| NET ASSETS consist of: |  |
| &nbsp;&nbsp; Paid in Capital  | $136592240 |
| &nbsp;&nbsp; Aggregate distributable earnings (losses)  | (14416283) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Net Assets  | $122175957 |
| Common shares issued and outstanding  | 14295539 |
| Net asset value per common share  | $8.55 |

---

See accompanying notes to the consolidated financial statements <br>

13 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Schedule of Investments** <br>As of June 30, 2025 <br>(expressed in U.S. dollars) <br>(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Issuer<sup>(1)</sup>**  | **Investment<sup>(2)</sup>**  | **Acquisition <br> Date<sup>(3)</sup>**  | **Principal <br> Amount**  | **Cost**  | **Fair Value<sup>(4)</sup>**  | **% of Net <br> Assets**  |
| **Investments at Fair Value<sup>(5)(11)</sup>** |  |  |  |  |  |  |
| &nbsp;&nbsp; **Collateralized Loan Obligation Debt<sup>(6)</sup>**  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Structured Finance  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bain Capital Credit CLO 2021-5, Limited  | Secured Note – Class E, 11.04% (3M SOFR + 6.76%, due 10/23/2034) | 10/28/24  | $3000000 | $2914260 | $2896800 | 2.37% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neuberger Berman Loan Advisers CLO 43, Ltd.  | Secured Note – Class E-R, 8.88% (3M SOFR + 4.60%, due 07/17/2036) | 06/26/25  | 3000000 | 2950109 | 2953200 | 2.42% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dryden 92 CLO, Ltd.  | Secured Note – Class E, 11.08% (3M SOFR + 6.76%, due 11/20/2034) | 10/29/24  | 3000000 | 2948004 | 2951400 | 2.42% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; KKR CLO 17 Ltd.  | Secured Note – Class E-R, 11.91% (3M SOFR + 7.65%, due 04/15/2034) | 10/25/24  | 3000000 | 2990641 | 2883000 | 2.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tralee CLO VII, Ltd.  | Secured Note – Class E, 11.93% (3M SOFR + 7.65%, due 04/25/2034) | 06/02/22  | 550000 | 497872 | 549945 | 0.45% |
| &nbsp;&nbsp; **Total Collateralized Loan Obligation Debt**  |  |  |  | 12300886 | 12234345 | 10.02% |
| &nbsp;&nbsp; **Collateralized Loan Obligation Equity<sup>(7)(8)</sup>**  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Structured Finance  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AMMC CLO 28, Limited  | Subordinated Note (effective yield 16.23%, maturity 07/20/2037) | 01/28/25  | 2400000 | 1864708 | 1822052 | 1.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AMMC CLO 30, Limited  | Subordinated Note (effective yield 14.69%, maturity 01/15/2037) | 11/01/24  | 4725000 | 3590183 | 3249441 | 2.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ares LXII CLO Ltd.  | Subordinated Note (effective yield 12.95%, maturity 01/25/2034) | 01/18/24  | 4750000 | 2940349 | 2308565 | 1.89% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ares LXIV CLO Ltd.  | Subordinated Note (effective yield 14.16%, maturity 04/15/2035) | 01/26/23  | 1064500 | 647544 | 597251 | 0.49% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ares LXV CLO Ltd.  | Subordinated Note (effective yield 14.35%, maturity 07/25/2034) | 04/16/24  | 1050000 | 678764 | 592098 | 0.48% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ares LXIX CLO Ltd.  | Income Note (effective yield 16.61%, maturity 04/15/2037)<sup>(9)</sup> | 01/31/24  | 4850000 | 3079125 | 2878298 | 2.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ares LXXII CLO Ltd.  | Income Note (effective yield 16.51%, maturity 07/15/2036)<sup>(9)</sup> | 06/21/24  | 4050000 | 2775197 | 2756075 | 2.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ares LXXVI CLO Ltd.  | Income Note (effective yield 16.66%, maturity 05/27/2038)<sup>(9)</sup> | 04/14/25  | 2825000 | 2023063 | 2038944 | 1.67% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ares Loan Funding IV, Ltd.  | Subordinated Note (effective yield 9.66%, maturity 10/15/2036) | 04/23/24  | 4925000 | 3374652 | 2839489 | 2.32% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bain Capital Credit CLO 2021-2, Limited  | Subordinated Note (effective yield 8.88%, maturity 07/16/2034) | 08/09/23  | 4250000 | 2008283 | 1579356 | 1.29% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bain Capital Credit CLO 2021-7, Limited  | Subordinated Note (effective yield 11.68%, maturity 01/22/2035) | 09/05/23  | 3450000 | 1886455 | 1540602 | 1.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bardot CLO, Ltd.  | Subordinated Note (effective yield 12.42%, maturity 10/22/2032)<sup>(9)</sup> | 11/22/22  | 275000 | 135944 | 84133 | 0.07% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Barings CLO Ltd. 2021-II  | Subordinated Note (effective yield 9.05%, maturity 07/15/2034) | 09/07/22  | 600000 | 364251 | 281281 | 0.23% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Barings CLO Ltd. 2022-II  | Income Note (effective yield 32.59%, maturity 07/15/2072)<sup>(9)</sup> | 06/21/22  | 1000000 | 341113 | 495863 | 0.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Barings CLO Ltd. 2022-IV  | Subordinated Note (effective yield 12.33%, maturity 10/20/2037) | 10/29/24  | 3500000 | 3010175 | 2650471 | 2.17% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Barings CLO Ltd. 2024-II  | Income Note (effective yield 18.27%, maturity 07/15/2039)<sup>(9)</sup> | 05/31/24  | 4300000 | 2723138 | 2927278 | 2.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Battalion CLO XXIII Ltd.  | Income Note (effective yield 12.71%, maturity 07/15/2036)<sup>(9)</sup> | 05/19/22  | 1225000 | 565711 | 443876 | 0.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bear Mountain Park CLO, Ltd.  | Income Note (effective yield 25.41%, maturity 07/15/2035)<sup>(9)</sup> | 07/13/22  | 550000 | 428801 | 552851 | 0.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Belmont Park CLO, Ltd.  | Income Note (effective yield 13.02%, maturity 04/15/2037)<sup>(9)</sup> | 02/21/24  | 3450000 | 2241316 | 2015829 | 1.65% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BlueMountain CLO XXIV Ltd.  | Subordinated Note (effective yield 9.69%, maturity 04/20/2034) | 05/31/22  | 750000 | 422488 | 262219 | 0.21% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carlyle US CLO 2017-2, Ltd.  | Subordinated Note (effective yield 14.22%, maturity 07/20/2037) | 10/09/24  | 13300000 | 2711913 | 2206816 | 1.81% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carlyle US CLO 2021-6 Ltd.  | Subordinated Note (effective yield 20.76%, maturity 07/15/2034) | 09/06/24  | 5000000 | 2164616 | 2462151 | 2.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carlyle US CLO 2021-10, Ltd.  | Subordinated Note (effective yield 15.11%, maturity 10/20/2034) | 08/16/23  | 4307000 | 2102510 | 1975224 | 1.62% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carlyle US CLO 2022-2, Ltd.  | Subordinated Note (effective yield 11.57%, maturity 04/20/2035) | 08/15/23  | 3482000 | 2272248 | 1921300 | 1.57% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carlyle US CLO 2022-4, Ltd.  | Subordinated Note (effective yield 13.81%, maturity 07/25/2036) | 10/29/24  | 3425000 | 3231288 | 2970824 | 2.43% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carlyle US CLO 2022-5, Ltd.  | Subordinated Note (effective yield 17.87%, maturity 10/15/2037) | 05/02/25  | 1575000 | 978469 | 1014057 | 0.83% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carlyle US CLO 2023-3, Ltd.  | Income Note (effective yield 3.81%, maturity 10/15/2036)<sup>(9)</sup> | 07/06/23  | 1000000 | 696965 | 622581 | 0.51% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CBAM 2019-9, Ltd.  | Subordinated Note (effective yield 12.28%, maturity 07/15/2037) | 11/01/24  | 8550000 | 2985536 | 3121166 | 2.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2017-I, Ltd.  | Subordinated Note (effective yield 11.61%, maturity 04/21/2037) | 10/09/24  | 5000000 | 2118654 | 1804250 | 1.48% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2017-III, Ltd.  | Subordinated Note (effective yield 12.07%, maturity 07/20/2030) | 10/09/24  | 5800000 | 2101573 | 1744374 | 1.43% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2017-V, Ltd.  | Subordinated Note (effective yield 11.95%, maturity 07/17/2037) | 10/30/24  | 1000000 | 462448 | 399151 | 0.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2019-II Ltd.  | Subordinated Note (effective yield 12.46%, maturity 04/17/2030) | 09/10/24  | 4510000 | 2953734 | 2678987 | 2.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2019-V, Ltd.  | Subordinated Note (effective yield 11.20%, maturity 01/15/2035) | 02/07/23  | 800000 | 528324 | 460035 | 0.38% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2019-VI Ltd.  | Subordinated Note (effective yield 11.34%, maturity 01/16/2033) | 09/10/24  | 3700000 | 2783237 | 2416042 | 1.98% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2020-II, Ltd.  | Income Note (effective yield 12.85%, maturity 10/20/2034) | 11/05/24  | 200000 | 131418 | 109193 | 0.09% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2020-II, Ltd.  | Subordinated Note (effective yield 12.85%, maturity 10/20/2034) | 12/14/22  | 650000 | 408431 | 353783 | 0.29% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2021-V, Ltd.  | Subordinated Note (effective yield 15.34%, maturity 01/15/2038) | 05/08/25  | 5043215 | 3183782 | 3215233 | 2.63% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2022-IV, Ltd.  | Subordinated Note (effective yield 11.70%, maturity 07/16/2035) | 10/23/23  | 2400000 | 1787930 | 1590352 | 1.30% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2022-VI, Ltd.  | Income Note (effective yield 19.65%, maturity 07/16/2035)<sup>(9)</sup> | 08/01/22  | 600000 | 426289 | 501889 | 0.41% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2023-I, Ltd.  | Income Note (effective yield 11.59%, maturity 10/15/2037)<sup>(9)</sup> | 09/14/23  | 4350000 | 3182453 | 3416152 | 2.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CIFC Funding 2025-II Ltd.  | Income Note (effective yield 16.48%, maturity 04/15/2038)<sup>(9)</sup> | 02/07/25  | 5000000 | 4091065 | 4470699 | 3.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clover CLO 2019-1 Ltd.  | Subordinated Note (effective yield 17.18%, maturity 04/18/2035) | 02/15/24  | 3306800 | 2266271 | 2174610 | 1.78% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clover CLO 2021-2, Ltd.  | Subordinated Note (effective yield 17.69%, maturity 07/20/2034) | 08/09/23  | 2150000 | 1333979 | 1424399 | 1.17% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Croton Park CLO, Ltd.  | Subordinated Note (effective yield 14.36%, maturity 10/15/2036) | 06/25/25  | 5000000 | 4056250 | 4048790 | 3.31% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Danby Park CLO, Ltd.  | Subordinated Note (effective yield 10.04%, maturity 10/21/2035) | 10/31/24  | 2950000 | 2986875 | 2421802 | 1.98% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dryden 78 CLO Ltd.  | Subordinated Note (effective yield 10.60%, maturity 04/17/2033) | 07/31/24  | 5950000 | 2847784 | 2379948 | 1.95% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dryden 94 CLO, Ltd.  | Income Note (effective yield 5.82%, maturity 07/15/2037)<sup>(9)</sup> | 04/28/22  | 4775000 | 2743216 | 1865535 | 1.53% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dryden 109 CLO, Ltd.  | Subordinated Note (effective yield 17.56%, maturity 04/20/2035)<sup>(9)</sup> | 02/15/23  | 4625000 | 2309928 | 2389073 | 1.96% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Eaton Vance CLO 2020-1, Ltd.  | Subordinated Note (effective yield 15.47%, maturity 10/15/2034)<sup>(9)</sup> | 08/08/23  | 2435000 | 1431191 | 1344763 | 1.10% |

---

See accompanying notes to the consolidated financial statements <br>

14 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Schedule of Investments** <br>As of June 30, 2025 <br>(expressed in U.S. dollars) <br>(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Issuer<sup>(1)</sup>**  | **Investment<sup>(2)</sup>**  | **Acquisition <br> Date<sup>(3)</sup>**  | **Principal <br> Amount**  | **Cost**  | **Fair Value<sup>(4)</sup>**  | **% of Net <br> Assets**  |
| &nbsp;&nbsp; **Collateralized Loan Obligation Equity<sup>(7)(8)</sup> (continued)**  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Structured Finance (continued)  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States (continued)  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Eaton Vance CLO 2020-2, Ltd.  | Subordinated Note (effective yield 14.87%, maturity 01/15/2035)<sup>(9)</sup> | 09/16/22  | $800000 | $487663 | $440526 | 0.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elmwood CLO 14 Ltd.  | Subordinated Note (effective yield 4.58%, maturity 04/20/2035) | 06/06/23  | 1000000 | 637980 | 494334 | 0.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elmwood CLO 21 Ltd.  | Subordinated Note (effective yield 3.20%, maturity 10/20/2036) | 10/26/23  | 2900000 | 1733873 | 1410204 | 1.15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generate CLO 3 Ltd.  | Subordinated Note (effective yield 3.11%, maturity 10/20/2036) | 04/23/24  | 5874000 | 3222223 | 2212602 | 1.81% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generate CLO 4 Ltd.  | Subordinated Note (effective yield 10.20%, maturity 04/20/2032) | 09/24/24  | 1125000 | 829958 | 636453 | 0.52% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generate CLO 9 Ltd.  | Subordinated Note (effective yield 13.84%, maturity 10/20/2034) | 05/31/22  | 600000 | 419252 | 369663 | 0.30% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invesco CLO 2022-2, Ltd.  | Subordinated Note (effective yield 11.60%, maturity 07/20/2035) | 08/14/24  | 1550000 | 872786 | 741406 | 0.61% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invesco CLO 2022-2, Ltd.  | Class Y Note (effective yield 11.60%, maturity 07/20/2035) | 08/14/24  | 120000 | 21739 | 23017 | 0.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invesco CLO 2022-3, Ltd.  | Subordinated Note (effective yield 12.28%, maturity 10/22/2037) | 10/29/24  | 3850000 | 2910295 | 2254443 | 1.85% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invesco CLO 2022-3, Ltd.  | Class Y Note (effective yield 12.28%, maturity 10/22/2037) | 10/29/24  | 385000 |  | 167292 | 0.14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kings Park CLO, Ltd.  | Subordinated Note (effective yield 15.83%, maturity 01/21/2035) | 04/27/23  | 925000 | 493312 | 411225 | 0.34% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lake George Park CLO, Ltd.  | Income Note (effective yield 19.39%, maturity 04/15/2038)<sup>(9)</sup> | 02/18/25  | 4750000 | 3891941 | 4335067 | 3.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Madison Park Funding XX, Ltd.  | Subordinated Note (effective yield 14.69%, maturity 07/27/2030) | 02/06/25  | 4050000 | 1026094 | 949675 | 0.78% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Madison Park Funding XXVIII, Ltd.  | Subordinated Note (effective yield 19.94%, maturity 07/15/2030) | 05/13/25  | 7600000 | 3002000 | 3195383 | 2.62% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Madison Park Funding XXXIV, Ltd.  | Subordinated Note (effective yield 16.96%, maturity 04/25/2048) | 09/27/22  | 1162000 | 595397 | 584528 | 0.48% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Madison Park Funding LII, Ltd.  | Subordinated Note (effective yield 6.11%, maturity 01/22/2035) | 03/13/24  | 4200000 | 2602549 | 1776218 | 1.45% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Madison Park Funding LXII, Ltd.  | Subordinated Note (effective yield 7.40%, maturity 07/17/2036) | 07/27/23  | 1300000 | 905840 | 688614 | 0.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Madison Park Funding LXIX, Ltd.  | Subordinated Note (effective yield 15.02%, maturity 07/25/2037) | 05/22/25  | 1100000 | 859375 | 856057 | 0.70% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Meacham Park CLO, Ltd.  | Subordinated Note (effective yield 12.92%, maturity 10/20/2037) | 01/24/25  | 4150000 | 3136449 | 2931029 | 2.40% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Morgan Stanley Eaton Vance CLO 2023-20, Ltd.  | Subordinated Note (effective yield 9.82%, maturity 01/20/2037) | 05/08/24  | 3780000 | 2764512 | 2367634 | 1.94% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCP CLO 2019-17, Ltd.  | Preferred Share (effective yield 10.62%, maturity 07/20/2037) | 09/03/24  | 4940000 | 2896288 | 2461174 | 2.01% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCP CLO 2020-20, Ltd.  | Subordinated Note (effective yield 8.99%, maturity 04/18/2037) | 04/25/24  | 2000000 | 1484591 | 1173871 | 0.96% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCP CLO 2021-22, Ltd.  | Subordinated Note (effective yield 11.31%, maturity 12/02/2034) | 05/08/24  | 3425000 | 2330372 | 1921893 | 1.57% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCP CLO 2022-24, Ltd.  | Subordinated Note (effective yield 10.22%, maturity 10/20/2037) | 10/29/24  | 4000000 | 2900329 | 2463787 | 2.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCP CLO 2023-30, Ltd.  | Subordinated Note (effective yield 6.37%, maturity 01/24/2037) | 05/10/24  | 4425000 | 3381037 | 2969939 | 2.43% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OCP CLO 2024-36, Ltd.  | Subordinated Note (effective yield 14.42%, maturity 10/16/2037) | 05/15/25  | 3750000 | 2980313 | 2986478 | 2.44% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Octagon Investment Partners 38, Ltd.  | Subordinated Note (effective yield 16.59%, maturity 07/20/2030) | 10/29/24  | 13965030 | 2967569 | 2675935 | 2.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Octagon Investment Partners 45, Ltd.  | Subordinated Note (effective yield 8.40%, maturity 04/15/2035) | 07/27/23  | 1600000 | 805487 | 466173 | 0.38% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Octagon 58, Ltd.  | Income Note (effective yield 12.55%, maturity 07/15/2037)<sup>(9)</sup> | 04/21/22  | 3150000 | 3157840 | 2675459 | 2.19% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Park Blue CLO 2024-V, Ltd.  | Subordinated Note (effective yield 16.68%, maturity 07/25/2037) | 10/09/24  | 3750000 | 2624937 | 2474642 | 2.03% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Point Au Roche Park CLO, Ltd.  | Subordinated Note (effective yield 12.15%, maturity 07/20/2034) | 08/07/23  | 2275000 | 1314211 | 1061937 | 0.87% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rad CLO 3 Ltd.  | Subordinated Note (effective yield 24.90%, maturity 04/15/2032)<sup>(9)</sup> | 04/22/25  | 7275000 | 3364687 | 3835288 | 3.14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reese Park CLO, Ltd.  | Subordinated Note (effective yield 20.19%, maturity 01/15/2038) | 05/08/25  | 5350000 | 2993325 | 2878125 | 2.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reese Park CLO, Ltd.  | Class M2 Note (effective yield 20.19%, maturity 01/15/2038) | 05/08/25  | 6955000 | 7 | 326512 | 0.27% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regatta XII Funding Ltd.  | Subordinated Note (effective yield 12.70%, maturity 10/15/2032) | 12/12/24  | 3550000 | 1935710 | 1624033 | 1.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regatta XII Funding Ltd.  | Class R1A Note (effective yield 12.70%, maturity 10/15/2037) | 12/12/24  | 6636950 | 16029 | 22380 | 0.02% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regatta XII Funding Ltd.  | Class R2 Note (effective yield 12.70%, maturity 10/15/2037) | 12/12/24  | 6636950 | 144264 | 201419 | 0.16% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regatta XVII Funding Ltd.  | Subordinated Note (effective yield 13.12%, maturity 10/15/2037) | 11/19/24  | 3722500 | 2674077 | 2349172 | 1.92% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regatta XXI Funding Ltd.  | Subordinated Note (effective yield 13.99%, maturity 10/20/2034) | 06/10/22  | 650000 | 400655 | 359281 | 0.29% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regatta XXII Funding Ltd.  | Subordinated Note (effective yield 20.78%, maturity 07/20/2035) | 06/20/23  | 1312500 | 836268 | 893276 | 0.73% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regatta XXIV Funding Ltd.  | Subordinated Note (effective yield 17.55%, maturity 01/20/2035) | 12/27/24  | 700000 | 379250 | 386711 | 0.32% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rockford Tower CLO 2022-3, Ltd.  | Subordinated Note (effective yield 35.46%, maturity 01/20/2035)<sup>(9)</sup> | 07/27/23  | 1400000 | 596797 | 924318 | 0.76% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rockford Tower 2024-2 Ltd  | Subordinated Note (effective yield 18.11%, maturity 10/20/2037) | 02/14/25  | 1275000 | 1000761 | 999359 | 0.82% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RR 23 Ltd.  | Subordinated Note (effective yield 5.84%, maturity 10/15/2035) | 10/12/23  | 3250000 | 1820086 | 1895572 | 1.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RR 28 Ltd.  | Subordinated Note (effective yield 9.83%, maturity 04/15/2120) | 10/31/24  | 6450000 | 2902869 | 2844497 | 2.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shackleton 2019-XIV CLO, Ltd.  | Subordinated Note (effective yield 11.66%, maturity 07/20/2034) | 01/24/24  | 3800000 | 2586120 | 2413164 | 1.98% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Venture 45 CLO, Ltd.  | Subordinated Note (effective yield 6.54%, maturity 07/20/2035) | 09/19/22  | 1275000 | 624058 | 183195 | 0.15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wind River 2022-1 CLO Ltd.  | Subordinated Note (effective yield 2.01%, maturity 07/20/2035) | 08/15/23  | 3118610 | 1858395 | 959479 | 0.79% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wind River 2022-2 CLO Ltd.  | Income Note (effective yield 0.00%, maturity 07/20/2035) | 06/03/22  | 600000 | 356566 | 167227 | 0.14% |
| &nbsp;&nbsp; **Total Collateralized Loan Obligation Equity**  |  |  |  | 178125773 | 162858817 | 133.34% |

---

See accompanying notes to the consolidated financial statements <br>

15 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Schedule of Investments** <br>As of June 30, 2025 <br>(expressed in U.S. dollars) <br>(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Issuer<sup>(1)</sup>**  | **Investment<sup>(2)</sup>**  | **Acquisition <br> Date<sup>(3)</sup>**  | **Principal <br> Amount**  | **Cost**  | **Fair Value<sup>(4)</sup>**  | **% of Net <br> Assets**  |
| &nbsp;&nbsp; **Loan Accumulation Facilities<sup>(8)(10)</sup>**  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Structured Finance  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steamboat LII Ltd.  | Loan Accumulation Facility | 10/09/24  | $4000000 | $4000000 | $4006349 | 3.28% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steamboat LIII Ltd.  | Loan Accumulation Facility | 06/24/25  | 2109375 | 2109375 | 2109375 | 1.73% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steamboat LV Ltd.  | Loan Accumulation Facility | 06/16/25  | 168250 | 168250 | 168250 | 0.14% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steamboat LVI Ltd.  | Loan Accumulation Facility | 05/27/25  | 1535625 | 1535625 | 1535838 | 1.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steamboat LVII Ltd.  | Loan Accumulation Facility | 05/02/25  | 313000 | 313000 | 313393 | 0.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steamboat LIX Ltd.  | Loan Accumulation Facility | 06/23/25  | 266500 | 266500 | 266500 | 0.22% |
| &nbsp;&nbsp; **Total Loan Accumulation Facilities**  |  |  |  | 8392750 | 8399705 | 6.89% |
| **Total investments at fair value as of June 30, 2025**  |  |  |  | $198819409 | $183492867 | 150.25% |
| **Net assets above (below) fair value of investments**  |  |  |  |  | (61316910) |  |
| **Net Assets as of June 30, 2025**  |  |  |  |  | $122175957 |  |

---

<sup>(1)</sup> The Fund is not affiliated with, nor does it "control" (as such term is defined in the Investment Company Act of 1940, as amended (the "1940 Act")), any of the issuers listed. In general, under the 1940 Act, the Fund would be presumed to "control" an issuer if it owned 25% or more of its voting securities.

<sup>(2)</sup> All securities exempt from registration under the Securities Act of 1933, as amended, and are deemed to be "restricted securities". 

<sup>(3)</sup> Acquisition date represents the initial purchase date of investment. 

<sup>(4)</sup> Fair value is determined by the Adviser in accordance with written valuation policies and procedures, subject to oversight by the Fund's Board of Trustees, in accordance with Rule 2a-5 under the 1940 Act.

<sup>(5)</sup> Country represents the principal country of risk where the investment has exposure. 

<sup>(6)</sup> Variable rate investment. Interest rate shown reflects the rate in effect at the reporting date. Investment description includes the reference rate and spread. 

<sup>(7)</sup> CLO subordinated notes and income notes are considered CLO equity positions. CLO equity positions are entitled to recurring distributions which are generally equal to the remaining cash flow of payments made by underlying assets less contractual payments to debt holders and fund expenses. The effective yield is estimated based upon the current projection of the amount and timing of these recurring distributions in addition to the estimated amount of terminal principal payment. It is the Fund's policy to update the effective yield for each CLO equity position held within the Fund's portfolio at the initiation of each investment and each subsequent quarter thereafter. The effective yield and investment cost may ultimately not be realized. As of June 30, 2025, the Fund's weighted average effective yield on its aggregate CLO equity positions, based on current amortized cost, was 13.19%.

<sup>(8)</sup> Classified as Level III investments. 

<sup>(9)</sup> Fair value includes the Fund's interest in fee rebates on CLO subordinated and income notes. 

<sup>(10)</sup> Loan accumulation facilities are financing structures intended to aggregate loans that may be used to form the basis of a CLO vehicle. 

<sup>(11)</sup> Pursuant to the terms of the credit facility agreement, a security interest in favor of the lender has been granted with respect to all investments. See Note 8 "Revolving Credit Facility" for further discussion. 

---

| | |
|:---|:---|
|  | **<u>Reference Key:</u>** |
| SOFR | Secured Overnight Financing Rate |

---

See accompanying notes to the consolidated financial statements <br>

16 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Statement of Operations** <br>For the six months ended June 30, 2025 <br>(expressed in U.S. dollars) <br>(Unaudited)

---

| | |
|:---|:---|
| INVESTMENT INCOME |  |
| &nbsp;&nbsp;&nbsp; Interest income  | $11560980 |
| &nbsp;&nbsp;&nbsp; Other income  | 242756 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investment Income  | 11803736 |
| EXPENSES |  |
| &nbsp;&nbsp;&nbsp; Interest expense  | 3125852 |
| &nbsp;&nbsp;&nbsp; Management fee  | 1465581 |
| &nbsp;&nbsp;&nbsp; Incentive fee  | 1239736 |
| &nbsp;&nbsp;&nbsp; Amortization of deferred offering costs attributed to common shares  | 461422 |
| &nbsp;&nbsp;&nbsp; Professional fees  | 350445 |
| &nbsp;&nbsp;&nbsp; Transfer agent fees  | 242821 |
| &nbsp;&nbsp;&nbsp; Administration fees  | 237912 |
| &nbsp;&nbsp;&nbsp; Trustees' fees  | 53250 |
| &nbsp;&nbsp;&nbsp; Other expenses  | 129194 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Expenses  | 7306213 |
| NET INVESTMENT INCOME  | 4497523 |
| NET REALIZED AND UNREALIZED GAIN (LOSS) |  |
| &nbsp;&nbsp;&nbsp; Net realized gain (loss) on investments  | (58111) |
| &nbsp;&nbsp;&nbsp; Net change in unrealized appreciation (depreciation) on investments  | (10264643) |
| NET REALIZED AND UNREALIZED GAIN (LOSS)  | (10322754) |
| NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  | $(5825231) |

---

See accompanying notes to the consolidated financial statements <br>

17 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Statements of Changes in Net Assets** <br>(expressed in U.S. dollars, except share amounts) <br>(Unaudited)

---

| | | |
|:---|:---|:---|
| | **For the <br> six months ended <br> June 30, 2025**  | **For the <br> year ended <br> December 31, 2024**  |
|  Net Increase (decrease) in net assets resulting from <br> operations:  |  |  |
| &nbsp;&nbsp;&nbsp; Net investment income  | $4497523 | $7109025 |
| &nbsp;&nbsp;&nbsp; Net realized gain (loss) on investments  | (58111) | 109152 |
| &nbsp;&nbsp;&nbsp; Net change in unrealized appreciation (depreciation) on investments  | (10264643) | (4918729) |
| Total net increase (decrease) in net assets resulting from operations  | (5825231) | 2299448 |
| Distributions to shareholders: |  |  |
| &nbsp;&nbsp;&nbsp; Total earnings earnings distributed  | (6284108) | (7865585) |
| &nbsp;&nbsp;&nbsp; Distributions from tax return of capital  |  |  |
| Total distributions to shareholders  | (6284108) | (7865585) |
| Capital share transactions: |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from shares sold  | 29638130 | 63197675 |
| &nbsp;&nbsp;&nbsp; Reinvestment of distributions resulting in the issuance of shares  | 2425328 | 2881994 |
| &nbsp;&nbsp;&nbsp; Repurchase of shares  | (4014478) | (3424426) |
| Total increase (decrease) in net assets from capital transactions  | 28048980 | 62655243 |
| Total increase (decrease) in net assets  | 15939641 | 57089106 |
| Net assets at beginning of period  | 106236316 | 49147210 |
| Net assets at end of period  | $122175957 | $106236316 |
| Capital share activity: |  |  |
| &nbsp;&nbsp;&nbsp; Shares sold  | 3387206 | 6286312 |
| &nbsp;&nbsp;&nbsp; Shares sold pursuant to the Fund's distribution reinvestment plan  | 292946 | 300404 |
| &nbsp;&nbsp;&nbsp; Repurchased shares  | (430380) | (344318) |
| Total increase (decrease) in capital share activity  | 3249772 | 6242398 |

---

See accompanying notes to the consolidated financial statements <br>

18 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Statement of Cash Flows** <br>For the six months ended June 30, 2025 <br>(expressed in U.S. dollars) <br>(Unaudited)

---

| | |
|:---|:---|
| CASH FLOWS FROM OPERATING ACTIVITIES: |  |
| &nbsp;&nbsp;&nbsp; Net increase (decrease) in net assets from operations  | $(5825231) |
| &nbsp;&nbsp;&nbsp; Adjustments to reconcile net increase (decrease) in net assets from operations to net cash provided by (used in) operating activities:  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Purchase of investments  | (57812549) |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from sales of investments and repayments of principal<sup>(1)</sup>  | 17411927 |
| &nbsp;&nbsp;&nbsp;&nbsp; Net realized (gain) loss on investments  | 58111 |
| &nbsp;&nbsp;&nbsp;&nbsp; Net change in unrealized (appreciation) depreciation on investments  | 10264643 |
| &nbsp;&nbsp;&nbsp;&nbsp; Amortization of deferred issuance costs attributed to preferred stock  | 610457 |
| &nbsp;&nbsp;&nbsp;&nbsp; Amortization of deferred financing costs attributed to revolving credit facility  | 87555 |
| &nbsp;&nbsp;&nbsp;&nbsp; Amortization of deferred offering costs attributed to common shares  | 461422 |
| &nbsp;&nbsp;&nbsp;&nbsp; Amortization (accretion) of premiums or discounts on CLO debt securities  | (6963) |
| &nbsp;&nbsp;&nbsp;&nbsp; Change in assets and liabilities:  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest receivable  | 53002 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses  | (17778) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Due from Adviser  | 1665553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other assets  | (5303) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Incentive fee payable  | (469616) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Management fee payable  | (1181478) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest payable  | (182683) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Due to custodian  | 1591112 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Professional fees payable  | (3665) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Administration fees payable  | (6255) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer agent fees payable  | 50256 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other expenses payable  | (108914) |
| &nbsp;&nbsp;&nbsp; Net cash provided by (used in) operating activities  | (33366397) |
| CASH FLOWS FROM FINANCING ACTIVITIES: |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Borrowings under credit facility  | 6700000 |
| &nbsp;&nbsp;&nbsp;&nbsp; Repayments under credit facility  | (26200000) |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from issuance of Series B Term Preferred Shares due 2030  | 30000000 |
| &nbsp;&nbsp;&nbsp;&nbsp; Issuance costs, paid and deferred  | (968643) |
| &nbsp;&nbsp;&nbsp;&nbsp; Distributions to shareholders, net of reinvestment  | (3858780) |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from shares sold  | 30567225 |
| &nbsp;&nbsp;&nbsp;&nbsp; Repurchase of shares  | (4014478) |
| &nbsp;&nbsp;&nbsp;&nbsp; Offering costs, paid and deferred  | (202032) |
| &nbsp;&nbsp;&nbsp;&nbsp; Net cash provided by (used in) financing activities  | 32023292 |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS  | (1343105) |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD  | 1343105 |
| CASH AND CASH EQUIVALENTS, END OF PERIOD  | $— |
| &nbsp;&nbsp;&nbsp; Supplemental disclosures:  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cash paid for interest expense  | $2754992 |

---

<sup>(1)</sup> <br>

Proceeds from sales or maturity of investments includes $5,239,532 of return of capital on CLO equity investments from recurring cash flows.

See accompanying notes to the consolidated financial statements <br>

19 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

1. <br>

#### ORGANIZATION
Eagle Point Institutional Income Fund (the "Fund") was formed as a Delaware statutory trust on October 22, 2021, and is an externally managed, non-diversified closed-end management investment company registered under the Investment Company Act of 1940, as amended (the "1940 Act"). The Fund's primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objectives by investing primarily in equity and junior debt tranches of collateralized loan obligations ("CLOs") that are collateralized by a portfolio consisting primarily of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. The Fund may also invest in other related securities and instruments or other securities and instruments that Eagle Point Credit Management LLC (the "Adviser") believes are consistent with the Fund's investment objectives, including senior debt tranches of CLOs, loan accumulation facilities ("LAFs") and securities and instruments of corporate issuers. From time to time, in connection with the acquisition of CLO equity, the Fund may receive fee rebates from the CLO issuer. The CLO securities in which the Fund primarily seeks to invest are unrated or rated below investment grade and are considered speculative with respect to timely payment of interest and repayment of principal.

The Fund commenced operations on June 1, 2022 and is offering its common shares of beneficial interest ("Shares") on a continuous basis at the applicable period end net asset value ("NAV") per share plus any applicable sales loads.

The Fund intends to operate so as to qualify to be taxed as a regulated investment company ("RIC") under subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"), for federal income tax purposes.

The Adviser is the investment adviser of the Fund and manages the investments of the Fund subject to the supervision of the Fund's Board of Trustees (the "Board"). The Adviser is registered as an investment adviser with the U.S. Securities and Exchange Commission (the "SEC") under the Investment Advisers Act of 1940, as amended. Eagle Point Administration LLC, an affiliate of the Adviser, is the administrator of the Fund (the "Administrator").

The consolidated financial statements include the accounts of the Fund and its wholly-owned subsidiaries: EPIIF Sub (Cayman) Ltd. ("Sub I") and EPIIF Sub II (Cayman) Ltd. ("Sub II"), each a Cayman Islands exempted company. All intercompany accounts and transactions have been eliminated upon consolidation. As of June 30, 2025, Sub I and Sub II represented 0.39% and 2.74% of the Fund's net assets, respectively.

2. <br>

#### SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

#### Basis of Accounting
The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles ("U.S. GAAP"). The Fund is an investment company and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 946 *Financial Services — Investment Companies*. Items included in the consolidated financial statements are measured and presented in U.S. dollars.

#### Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions which affect the reported amounts included in the consolidated financial statements and accompanying notes as of the reporting date. Actual results may differ from those estimates.

#### Operating Segments
The Fund has a single reportable segment with investment objectives described in Note 1 "Organization". The chief operating decision maker ("CODM") of the Fund is comprised of the Fund's Chief Executive Officer and

20 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

the Chief Financial Officer. Key financial information in the form of the Fund's portfolio composition, total return, changes in net assets and expense ratios which are used by the CODM to assess the Fund's performance and to make operational decisions for the Fund's single segment, is consistent with the presentation within the Fund's consolidated financial statements. Segment assets are reflected on the accompanying Consolidated Statement of Assets and Liabilities as "total assets" and significant segment expenses are listed on the Consolidated Statement of Operations.

#### Valuation of Investments
The most significant estimate inherent in the preparation of the consolidated financial statements is the valuation of investments.

The Fund accounts for its investments in accordance with U.S. GAAP, and fair values its investment portfolio in accordance with the provisions of the FASB ASC Topic 820*, Fair Value Measurements and Disclosures*, which defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements. Investments are reflected in the consolidated financial statements at fair value. Fair value is the estimated amount that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date (i.e., the exit price).

Pursuant to Rule 2a-5 under the 1940 Act adopted by the SEC in December 2020 ("Rule 2a-5"), the Board has elected to designate the Adviser as "valuation designee" to perform fair value determinations, subject to Board oversight and certain other conditions. In the absence of readily available market quotations, as defined by Rule 2a-5, the Adviser determines the fair value of the Fund's investments in accordance with its written valuation policy approved by the Board. There is no single method for determining fair value in good faith. As a result, determining fair value requires judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments held by the Fund. Due to the uncertainty of valuation, this estimate may differ significantly from the value that would have been used had a ready market for the investments existed, and the differences could be material.

The Fund determines fair value based on assumptions that market participants would use in pricing an asset or liability in an orderly transaction at the measurement date. When considering market participant assumptions in fair value measurements, the following fair value hierarchy prioritizes and ranks the level of market price observability used in measuring investments:

<u>Level I</u> — Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund is able to access as of the reporting date.

<u>Level II</u> — Inputs, other than quoted prices included in Level I, that are observable either directly or indirectly as of the reporting date. These inputs may include (a) quoted prices for similar assets in active markets, (b) quoted prices for identical or similar assets in markets that are not active, (c) inputs other than quoted prices that are observable for the asset, or (d) inputs derived principally from or corroborated by observable market data by correlation or other means.

<u>Level III</u> — Pricing inputs are unobservable for the investment and little, if any, active market exists as of the reporting date. Fair value inputs require significant judgment or estimation from the Adviser.

In certain cases, inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for any given investment is based on the lowest level of input significant to that fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and consideration of factors specific to the investment.

21 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

Market price observability is impacted by a number of factors, including the type of investment, the characteristics specific to the investment and the state of the marketplace (including the existence and transparency of transactions between market participants). Investments with readily available actively quoted prices, or for which fair value can be measured from actively quoted prices in an orderly market, will generally have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Investments for which observable, quoted prices in active markets do not exist are reported at fair value based on Level III inputs. The amount determined to be fair value may incorporate the Adviser's own assumptions (including assumptions the Adviser believes market participants would use in valuing investments and assumptions relating to appropriate risk adjustments for nonperformance and lack of marketability), as provided for in the Adviser's valuation policy.

An estimate of fair value is made for each investment at least monthly taking into account information available as of the reporting date.

See Note 3 "Investments" for further discussion relating to the Fund's investments.

#### Investment Income Recognition
Interest income from investments in CLO debt is recorded using the accrual basis of accounting to the extent such amounts are expected to be collected. Interest income on investments in CLO debt is generally expected to be received in cash. The Fund applies the provisions of Accounting Standards Update No. 2017-08 *Premium Amortization on Purchased Callable Debt Securities* ("ASU 2017-08") in calculating amortization of premium for purchased CLO debt securities. Amortization of premium or accretion of discount is recognized using the effective interest method.

In certain circumstances, all or a portion of interest income from a given investment may be paid in the form of additional investment principal, often referred to as payment-in-kind ("PIK") interest. PIK interest is included in interest income and interest receivable through the PIK capitalization date. On the capitalization date, the PIK component of interest receivable is capitalized as additional principal in the investment, which is subject to fair value determination, and the PIK interest rate is applied to the entire principal balance of the applicable investment. To the extent the Fund does not believe it will ultimately be able to collect capitalized PIK interest, the investment will be placed on non-accrual status, and previously recorded capitalized PIK interest will be reversed. The Fund had no investments with PIK interest as of June 30, 2025.

CLO equity investments and fee rebates recognize investment income for U.S. GAAP purposes on the accrual basis utilizing an effective interest methodology based upon an effective yield to maturity utilizing projected cash flows. ASC Topic 325-40, *Beneficial Interests in Securitized Financial Assets*, requires investment income from CLO equity investments and fee rebates to be recognized under the effective interest method, with any difference between cash distributed and the amount calculated pursuant to the effective interest method being recorded as an adjustment to the cost basis of the investment. It is the Fund's policy to update the effective yield for each CLO equity position held within the Fund's portfolio at the initiation of each investment and each subsequent quarter thereafter.

LAFs recognize interest income according to the guidance noted in ASC Topic 325-40-35-1, *Beneficial Interest in Securitized Financial Assets*, which states that the holder of a beneficial interest in securitized financial assets shall determine interest income over the life of the beneficial interest in accordance with the effective yield method, provided such amounts are expected to be collected. FASB ASC 325-40-20 further defines "beneficial interests," among other things, as "rights to receive all or portions of specified cash inflows received by a trust or other entity." FASB ASC 325-40-15-7 also states that for income recognition purposes, beneficial interests in securitized financial assets (such as those in LAFs) are within the scope of ASC 325-40 because it is customary for certain

22 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

industries, such as investment companies, to report interest income as a separate item in their income statements even though the investments are accounted for at fair value. The amount of interest income from LAFs recorded for the six months ended June 30, 2025 was $0.8 million.

#### Other Income
Other income includes the Fund's share of income under the terms of fee rebate agreements.

#### Interest Expense
Interest expense includes the Fund's distributions associated with its 8.125% Series A Term Preferred Shares due 2029 (the "Series A Term Preferred Shares") and 8.00% Series B Term Preferred Shares due 2030 (the "Series B Term Preferred Shares" and collectively with the Series A Term Preferred Shares, the "Preferred Shares"), amounts due under the Revolving Credit Facility (as defined below) in relation to outstanding borrowings and unused commitment fees and deferred financing and issuance costs associated with the Revolving Credit Facility and Preferred Shares.

The following table summarizes the components of interest expense for the six months ended June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Series A <br> Preferred Shares**  | **Series B <br> Preferred Shares**  | **Revolving <br> Credit Facility**  | **Total**  |
| Distributions declared and paid  | $1.4 | $0.5 | $— | $1.9 |
| Distributions accrued and unpaid  |  | 0.1 |  | 0.1 |
| Interest expense on credit facility  |  |  | 0.4 | 0.4 |
|  Amortization of deferred financing and issuance costs  | 0.5 | 0.1 | 0.1 | 0.7 |
| Total interest expense  | $1.9 | $0.7 | $0.5 | $3.1 |

---

Amounts in millions.

The Fund's Preferred Shares had $0.1 million in interest payable outstanding as of June 30, 2025.

Please refer to Note 8 "Revolving Credit Facility" and Note 9 "Mandatorily Redeemable Preferred Shares" for further discussion relating to the interest expense due under the Revolving Credit Facility and the Preferred Shares issuances, respectively.

#### Securities Transactions
The Fund records the purchase and sale of securities on trade date. Realized gains and losses on investments sold are recorded on the basis of the specific identification method.

#### Cash and Cash Equivalents
The Fund has defined cash and cash equivalents as cash and short-term, highly liquid investments with original maturities of three months or less from the date of purchase. The Fund maintains its cash in bank accounts, which, at times, may exceed federal insured limits. The Adviser monitors the performance of the financial institution where the accounts are held in order to manage any risk associated with such accounts.

#### Expense Recognition
Expenses are recorded on the accrual basis of accounting.

#### Prepaid Expenses
Prepaid expenses consist primarily of insurance premiums and state registration fees. Insurance premiums are amortized over the term of the current insurance policy. State registration fees are amortized over twelve months from the time of payment.

23 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

#### Offering Costs Attributed to Common Shares
Offering costs of the Fund are capitalized and amortized to expense over the twelve month period following such capitalization on a straight line basis. Since inception of the Fund, a portion of the offering costs incurred by the Fund have been paid for by the Adviser, for which the Adviser has not yet sought reimbursement. See Note 4 "Related Party Transactions" for further discussion of the Fund's offering costs.

#### Organization Costs
Organizational costs of the Fund are expensed as incurred. Since inception, a portion of organizational costs incurred by the Fund have been paid for by the Adviser, for which the Adviser has not yet sought reimbursement. See Note 4 "Related Party Transactions" for further discussion of the Fund's organizational costs.

#### Deferred Financing and Issuance Costs
Deferred financing and issuance costs consist of fees and expenses incurred in connection with the Revolving Credit Facility and the issuance of Preferred Shares. The deferred financing and issuance costs are capitalized at the time of issuance and amortized using the effective interest method over the respective terms of the Revolving Credit Facility and Preferred Shares. Amortization of deferred financing and issuance costs is recorded as an interest expense on the Consolidated Statement of Operations.

#### Federal and Other Taxes
The Fund intends to operate so as to qualify to be taxed as a RIC under subchapter M of the Code and, as such, to not be subject to federal income tax on the portion of its taxable income and gains distributed to shareholders. To qualify for RIC tax treatment, among other requirements, the Fund is required to distribute at least 90% of its investment company taxable income, as defined by the Code.

Because U.S. federal income tax regulations differ from U.S. GAAP, distributions in accordance with tax regulations may differ from net investment income and realized capital gains recognized for financial reporting purposes. Differences may be permanent or temporary. Permanent differences are reclassified among capital accounts in the consolidated financial statements to reflect their tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future. Differences in classification may also result from the treatment of short-term capital gains as ordinary income for federal income tax purposes. The tax basis components of distributable earnings differ from the amounts reflected in the Consolidated Statement of Assets and Liabilities due to temporary book/tax differences arising primarily from partnerships and passive foreign investment company investments.

As of June 30, 2025, the federal income tax cost and net unrealized depreciation on securities were as follows:

---

| | |
|:---|:---|
| Cost for federal income tax purposes  | $183670915 |
| Gross unrealized appreciation  | $8646405 |
| Gross unrealized depreciation  | (8824453) |
| Net unrealized appreciation  | $(178048) |

---

#### Distributions
The composition of distributions paid to common shareholders from net investment income and capital gains are determined in accordance with U.S. federal income tax regulations, which differ from U.S. GAAP. Distributions to common shareholders can be comprised of net investment income, net realized capital gains and return of capital for U.S. federal income tax purposes and are intended to be paid monthly. Distributions payable to common shareholders are recorded as a liability on ex-dividend date. If a common shareholder opts-in to the Fund's distribution reinvestment plan (the "DRIP"), distributions are automatically reinvested in full common shares of

24 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

the Fund as of the payment date, pursuant to the DRIP. The Fund's common shareholders who choose not to participate in the DRIP generally will receive all distributions in cash.

In addition to the regular monthly distributions, and subject to available taxable earnings of the Fund, the Fund may make periodic special distributions representing the excess of the Fund's net taxable income over the Fund's aggregate monthly distributions paid during the year (or for other purposes).

The characterization of distributions paid to common shareholders, as set forth in the Consolidated Financial Highlights, reflect estimates made by the Fund for U.S. federal income tax purposes. Such estimates are subject to change once the final determination of the source of all distributions has been made and the final tax return has been filed by the Fund.

For the six months ended June 30, 2025, the Fund declared distributions to common shareholders of $6.3 million or $0.498 per common share.

3. <br>

#### INVESTMENTS

#### Fair Value Measurement
The following tables summarize the valuation of the Fund's investments measured and reported at fair value under the fair value hierarchy levels described in Note 2 "Summary of Significant Accounting Policies" as of June 30, 2025:

#### Fair Value Measurement (in millions)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Level I**  | **Level II**  | **Level III**  | **Total**  |
| <u>Investments at Fair Value</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp; CLO Debt  | $&nbsp;&nbsp;&nbsp;&nbsp;— | $12.2 | $— | $12.2 |
| &nbsp;&nbsp;&nbsp; CLO Equity  |  |  | 162.9 | 162.9 |
| &nbsp;&nbsp;&nbsp; Loan Accumulation Facilities  |  |  | 8.4 | 8.4 |
| Total Investments at Fair Value  | $— | $12.2 | $171.3 | $183.5 |

---

#### Significant Unobservable Inputs
The following table summarizes the quantitative inputs and assumptions used for investments categorized within Level III of the fair value hierarchy as of June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quantitative Information about Level III Fair Value Measurements**  | **Quantitative Information about Level III Fair Value Measurements**  | **Quantitative Information about Level III Fair Value Measurements**  | **Quantitative Information about Level III Fair Value Measurements**  |
| **Assets**  | **Fair Value <br> (in millions)**  | **Valuation Techniques/<br>Methodologies**  | **Unobservable Inputs**  | **Range / Weighted <br> Average<sup>(1)</sup>**  |
| CLO Equity  | $160.3 | Discounted Cash Flows | Annual Default Rate<sup>(2)</sup> | 0.00% - 4.17%  |
|  |  |  | Annual Prepayment Rate<sup>(3)</sup>  | 25.00%  |
|  |  |  | Reinvestment Spread | 3.05% - 3.57% / 3.26%  |
|  |  |  | Reinvestment Price<sup>(2)</sup> | 98.5 - 99.5%  |
|  |  |  | Recovery Rate | 68.64% - 70.00% / 69.73%  |
|  |  |  | Expected Yield<sup>(4)</sup> | 4.52% - 74.76% / 16.76%  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(1)</sup> <br>

Weighted average calculations are based on the fair value of investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(2)</sup> <br>

A weighted average is not presented as the input in the discounted cash flow model varies over the life of an investment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(3)</sup> <br>

0% is assumed for defaulted and non-performing assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(4)</sup> <br>

Represents yield based on fair value and projected future cash flow.

25 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

In addition to the techniques and inputs noted in the above table, the Adviser may use other valuation techniques and methodologies when determining the fair value measurements of the Fund's investments, as provided for in the Adviser's valuation policy approved by the Board. Please refer to Note 2 "Valuation of Investments". The table is not intended to be all-inclusive, but rather provides information on the significant Level III inputs as they relate to the Fund's fair value measurements as of June 30, 2025. Unobservable inputs and assumptions are reviewed at each measurement date and updated as necessary to reflect current market conditions.

Increases (decreases) in the annual default rate, reinvestment price and expected yield in isolation would result in a lower (higher) fair value measurement. Increases (decreases) in the reinvestment spread and recovery rate in isolation would result in a higher (lower) fair value measurement. Changes in the annual prepayment rate may result in a higher (lower) fair value, depending on the circumstances. Generally, a change in the assumption used for the annual default rate may be accompanied by a directionally opposite change in the assumption used for the annual prepayment rate and recovery rate.

Certain of the Fund's Level III investments have been valued using unadjusted inputs that have not been internally developed by the Adviser, including third-party transactions, recent transactions and data reported by trustees. As a result, investments with a fair value of $8.4 million have been excluded from the preceding table. Additionally, the preceding table excludes $2.6 million of fair value pertaining to CLO equity with expected yields below 0% and over 100%.

#### Change in Investments Classified as Level III
The changes in investments classified as Level III are as follows for the six months ended June 30, 2025:

---

| | | |
|:---|:---|:---|
| | **CLO Equity**  | **Loan <br> Accumulation <br> Facilities**  |
| Balance as of December 31, 2024  | $135.3 | $8.6 |
| Purchases of investments  | 43.7 | 11.2 |
| Proceeds from sales, maturity of investments or return of capital  | (6.0)<sup>(1)</sup> | (11.4) |
|  Net realized gains (losses) and net change in unrealized appreciation (depreciation)  | (10.1) | 0.0 |
| Balance as of June 30, 2025<sup>(2)</sup>  | $162.9 | $8.4 |
|  Change in unrealized appreciation (depreciation) on investments still held as of <br> June 30, 2025  | $(9.9) | $— |

---

Amounts in millions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(1)</sup> <br>

Includes $5.2 million of return of capital on CLO equity investments from recurring cash flows.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(2)</sup> <br>

There were no transfers into or out of level III investments during the period.

The net realized gains (losses) recorded for Level III investments are reported in the net realized gain (loss) on investments account in the Consolidated Statement of Operations, if applicable. Net changes in unrealized appreciation (depreciation) are reported in the net change in unrealized appreciation (depreciation) on investments account in the Consolidated Statement of Operations.

#### Fair Value — Valuation Techniques and Inputs
The Adviser establishes valuation processes and procedures to ensure the valuation techniques are fair and consistent, and valuation inputs are supportable. The Adviser has a Valuation Committee comprised of various senior personnel of the Adviser, the majority of which are not members of the Fund's portfolio management function. The Valuation Committee is responsible for overseeing the valuation process, evaluating the overall

26 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

fairness and consistent application of the Adviser's written valuation policies approved by the Board. The Valuation Committee reviews and approves the valuation on a monthly basis.

#### Valuation of CLO Equity
The Adviser estimates the fair value of CLO equity investments utilizing the output from a third-party financial tool based on assumptions derived from internal and external (market) data. The tool contains detailed information on the characteristics of each CLO, including recent information about assets and liabilities from data sources such as trustee reports, and uses market data inputs to project future cash flows to CLO equity tranches. Key inputs to the tool, including, but not limited to assumptions for future loan default rates, recovery rates, prepayment rates, reinvestment rates and discount rates are determined by considering both observable and third-party market data and prevailing general market assumptions and conventions as well as those of the Adviser. Additionally, a third-party independent valuation firm is used as an input by the Adviser to determine the fair value of the Fund's investments in CLO equity. The valuation firm's advice is only one factor considered in the valuation of such investments, and the Adviser does not solely rely on such advice in determining the fair value of the Fund's investments in accordance with the 1940 Act.

The Adviser categorizes CLO equity as Level III investments. Certain pricing inputs may be unobservable. An active market may exist, but not necessarily for CLO equity investments that the Fund holds as of the reporting date.

#### Valuation of CLO Debt
The Fund's investments in CLO debt have been valued using an independent pricing service. The valuation methodology of the independent pricing service includes incorporating data comprised of observable market transactions, executable bids, broker quotes from dealers with two sided markets, as well as transaction activity from comparable securities to those being valued. As the independent pricing service contemplates real time market data and no unobservable inputs or significant judgment has been used by the Adviser in the valuation of the Fund's investment in CLO debt, such positions are considered Level II assets.

#### Valuation of Loan Accumulation Facilities
The Adviser determines the fair value of LAFs in accordance with FASB ASC Topic 820, Fair Value Measurements and Disclosures, utilizing the income approach as noted in ASC 820-10-55-3F (the "Income Approach"), in which fair value measurement reflects current market expectations about the receipt of future amounts (i.e., exit price). LAFs are typically short- to medium-term in nature and formed to acquire loans on an interim basis that are expected to form part of a specific CLO transaction. Pursuant to LAF governing documents, loans acquired by the LAF are typically required to be transferred to the contemplated CLO transaction at original cost plus accrued interest. In such situations, because the LAF will receive its full cost basis in the underlying loan assets and the accrued interest thereon upon the consummation of the CLO transaction, the Adviser determines the fair value of the LAF as follows: (A) the cost of the Fund's investment (i.e., the principal amount invested), and (B) to the extent the LAF has realized gains (losses) on its underlying loan assets which are reported by the trustee during the applicable reporting period, its attributable portion of such realized gains (losses).

In certain circumstances, the LAF documents can contemplate transferring the underlying loans at a price other than original cost plus accrued interest or the Adviser may determine that, despite the initial expectation that a CLO transaction would result from a LAF, such a transaction is in fact unlikely to occur and, accordingly, it is unlikely the loans held by the LAF will be transferred at cost. Rather, the loans held by the LAF will most likely be sold at market value. In such situations, the Adviser will continue to fair value the LAF consistent with the Income Approach, but modify the fair value measurement to reflect the change in exit strategy of the LAF to incorporate market expectations of the receipt of future amounts (i.e., exit price). As such, the fair value of the LAF is most appropriately determined by reference to the market value of the LAF's underlying loans, which is reflective of the

27 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

price at which the LAF could sell its loan assets in an orderly transaction between market participants. As such, in these situations, the Adviser will continue utilizing the Income Approach and determine the fair value of the LAF as follows: (A) the cost of the Fund's investment (i.e., the principal amount invested), (B) the Fund's attributable portion of the unrealized gain (loss) on the LAF's underlying loan assets, and (C) to the extent the LAF has realized gains (losses) on its underlying loan assets which are reported by the trustee during the applicable reporting period, its attributable portion of such realized gains (losses). The Adviser's measure of the Fund's attributable portion of the unrealized gain (loss) on the LAF's underlying loan assets takes into account the Adviser's current market expectations of the receipt of future amounts on such assets, which may be impacted by various factors including any applicable change in market conditions or new information.

The Adviser categorizes LAFs as Level III investments. There is no active market and prices are unobservable.

#### Investment Risk Factors
The following list is not intended to be a comprehensive list of the potential risks associated with the Fund. The Fund's prospectus provides a detailed discussion of the Fund's risks and considerations. The risks described in the prospectus are not the only risks the Fund faces. Additional risks and uncertainties not currently known to the Fund or that are currently deemed to be immaterial also may materially and adversely affect its business, financial condition and/or operating results.

#### Risks of Investing in CLOs and Other Structured Debt Securities
CLOs and similar structured finance securities in which the Fund invests are backed by a pool of credit-related assets that serve as collateral. Accordingly, such securities present risks similar to those of other types of credit investments, including default (credit), interest rate and prepayment risks. Adverse credit events impacting a CLO's or structured finance security's underlying collateral would be expected to reduce cash flows payable to the Fund as investor in the equity tranche. In addition, there is a risk that majority lenders to an underlying loan or other debt instrument held by a CLO or structured finance security could amend or otherwise modify the loan or debt instrument to the detriment of the CLO or structured finance security (including, for example, by transferring collateral or otherwise reducing the priority of the CLO's or structured finance security's investment within the borrower's capital structure). Such actions would impair the value of the CLO's or structured finance security's investment and, ultimately, the Fund In addition, CLOs and structured finance securities present risks related to the capability of the servicer of the securitized assets. CLOs and other structured finance securities are often governed by a complex series of legal documents and contracts, which increases the risk of dispute over the interpretation and enforceability of such documents relative to other types of investments. There is also a risk that the trustee or other servicer does not properly carry out its duties to the CLO or structured finance security, potentially resulting in loss. CLOs and certain structured finance securities are also inherently leveraged vehicles and therefore subject to leverage risk.

The Fund may also invest in structured securities that are collateralized by other types of assets. For example, the Fund may invest in collateralized fund obligations ("CFOs") or rated feeders, which typically consist of tranches of notes and/or equity issued by a special purpose vehicle that holds limited partnership interests in one or more private funds. Investments in CFOs and rated feeders are generally subject to the risks applicable to the underlying fund collateral, including uncertainty as to the amount and timing of underlying fund distributions, transfer restrictions and general illiquidity of underlying fund investments, dependence of the performance of the underlying funds' general partner and key personnel, leverage risks, and general market and economic factors.

#### Subordinated Securities Risk
CLO equity and junior debt securities that the Fund may acquire are subordinate to more senior tranches of CLO debt. CLO equity and junior debt securities are subject to increased risks of default relative to the holders of

28 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

superior priority interests in the same CLO. In addition, at the time of issuance, CLO equity securities are under-collateralized in that the face amount of the debt and equity of a CLO at inception exceeds the CLO's total assets. The Fund will typically be in a subordinated or first loss position with respect to realized losses on the underlying assets held by the CLOs in which the Fund is invested.

#### High Yield Investment Risk
The CLO equity and junior debt securities that the Fund acquires are typically rated below investment grade or, in the case of CLO equity securities, unrated and are therefore considered "higher yield" or "junk" securities and are considered speculative with respect to timely payment of interest and repayment of principal. The senior secured loans and other credit-related assets underlying CLOs are also typically higher yield investments. Investing in CLO equity and junior debt securities and other high yield investments involves greater credit and liquidity risk than investment grade obligations, which may adversely impact the Fund's performance.

#### Leverage Risk
The use of leverage, whether directly or indirectly through investments such as CLO equity or junior debt securities that inherently involve leverage, may magnify the Fund's risk of loss. CLO equity or junior debt securities are very highly leveraged (with CLO equity securities typically being leveraged ten times), and therefore the CLO securities in which the Fund invests are subject to a higher degree of risk of loss.

#### Credit Risk
If (1) a CLO in which the Fund invests, (2) an underlying asset of any such CLO or (3) any other type of credit investment in the Fund's portfolio declines in price or fails to pay interest or principal when due because the issuer or debtor, as the case may be, experiences a decline in its financial status, the Fund's income, NAV and/or market price would be adversely impacted. Additionally, interest on a CLO may be paid in kind or deferred and capitalized (paid in the form of obligations of the same type rather than cash), which involves continued exposure to default risk with respect to such payments.

#### Key Personnel Risk
The Adviser manages our investments. Consequently, the Fund's success depends, in large part, upon the services of the Adviser and the skill and expertise of the Adviser's professional personnel. There can be no assurance that the professional personnel of the Adviser will continue to serve in their current positions or continue to be employed by the Adviser. We can offer no assurance that their services will be available for any length of time or that the Adviser will continue indefinitely as the Fund's investment adviser.

#### Conflicts of Interest Risk
The Fund's executive officers and trustees, and the Adviser and certain of its affiliates and their officers and employees, including the members of the Investment Committee, have several conflicts of interest as a result of the other activities in which they engage. For example, the members of the Adviser's investment team are and may in the future become affiliated with entities engaged in business activities similar to ours and may have conflicts of interest in allocating their time. Moreover, each member of the Adviser's Investment Committee is engaged in other business activities which divert their time and attention. As a result of these separate business activities, the Adviser has conflicts of interest in allocating management time, services and functions among us, other advisory clients and other business ventures.

#### Prepayment Risk
The assets underlying the CLO securities in which the Fund invests are subject to prepayment by the underlying corporate borrowers. As such, the CLO securities and related investments in which the Fund invests are subject to prepayment risk. If the Fund or a CLO collateral manager are unable to reinvest prepaid amounts in a new

29 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

investment with an expected rate of return at least equal to that of the investment repaid, the Fund's investment performance will be adversely impacted.

#### Liquidity Risk
Generally, there is no public market for the CLO investments in which the Fund invests. As such, the Fund may not be able to sell such investments quickly, or at all. If the Fund is able to sell such investments, the prices the Fund receives may not reflect the Adviser's assessment of their fair value or the amount paid for such investments by the Fund.

#### Incentive Fee Risk
The Fund's incentive fee structure and the formula for calculating the fee payable to the Adviser may incentivize the Adviser to pursue speculative investments and use leverage in a manner that adversely impacts the Fund's performance.

#### Fair Valuation of the Fund's Portfolio Investments
Generally, there is no public market for the CLO investments and certain other credit assets in which the Fund may invest. The Adviser values these securities at least monthly, or more frequently as may be required from time to time, at fair value. The Adviser's determinations of the fair value of the Fund's investments have a material impact on the Fund's net earnings through the recording of unrealized appreciation or depreciation of investments and may cause the Fund's NAV on a given date to understate or overstate, possibly materially, the value that the Fund ultimately realizes on one or more of the Fund's investments.

#### Limited Investment Opportunities Risk
The market for CLO securities is more limited than the market for other credit related investments. The Fund can offer no assurances that sufficient investment opportunities for the Fund's capital will be available. In recent years there has been a marked increase in the number of, and flow of capital into, investment vehicles established to pursue investments in CLO securities whereas the size of the market is relatively limited. While the Fund cannot determine the precise effect of such competition, such increase may result in greater competition for investment opportunities, which may result in an increase in the price of such investments relative to the risk taken on by holders of such investments. Such competition may also result under certain circumstances in increased price volatility or decreased liquidity with respect to certain positions.

#### Non-Diversification Risk
The Fund is a non-diversified investment company under the 1940 Act and expects to hold a narrower range of investments than a diversified fund under the 1940 Act.

#### Market Risk
Political, regulatory, economic and social developments, and developments that impact specific economic sectors, industries or segments of the market, can affect the value of the Fund's investments. A disruption or downturn in the capital markets and the credit markets could impair the Fund's ability to raise capital, reduce the availability of suitable investment opportunities for the Fund, or adversely and materially affect the value of the Fund's investments, any of which would negatively affect the Fund's business. These risks may be magnified if certain events or developments adversely interrupt the global supply chain, and could affect companies worldwide.

#### Synthetic Investments Risk
The Fund may invest in synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial institutions, or acquire interests in lease agreements that have the general characteristics of loans and are treated as loans for withholding tax purposes. In addition to the credit

30 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

risks associated with the applicable reference assets, the Fund will usually have a contractual relationship only with the counterparty of such synthetic investment, and not with the reference obligor of the reference asset. Accordingly, the Fund generally will have no right to directly enforce compliance by the reference obligor with the terms of the reference asset nor will it have any rights of setoff against the reference obligor or rights with respect to the reference asset. The Fund will not directly benefit from the collateral supporting the reference asset and will not have the benefit of the remedies that would normally be available to a holder of such reference asset. In addition, in the event of the insolvency of the counterparty, the Fund may be treated as a general creditor of such counterparty, and will not have any claim with respect to the reference asset. Consequently, the Fund will be subject to the credit risk of the counterparty as well as that of the reference obligor. As a result, concentrations of synthetic securities in any one counterparty subjects the Fund to an additional degree of risk with respect to defaults by such counterparty as well as by the reference obligor.

#### Loan Accumulation Facilities Risk
The Fund may invest in LAFs which are short to medium term facilities often provided by the bank that will serve as placement agent or arranger on a CLO transaction and which acquire loans on an interim basis which are expected to form part of the portfolio of a future CLO. Investments in LAFs have risks similar to those applicable to investments in CLOs. Leverage is typically utilized in such a facility and as such the potential risk of loss will be increased for such facilities employing leverage. In the event a planned CLO is not consummated, or the loans are not eligible for purchase by the CLO, the Fund may be responsible for either holding or disposing of the loans. This could expose the Fund to credit and/or mark-to-market losses, and other risks.

#### Currency Risk
Although the Fund primarily makes investments denominated in U.S. dollars, the Fund may make investments denominated in other currencies. The Fund's investments denominated in currencies other than U.S. dollars will be subject to the risk that the value of such currency will decrease in relation to the U.S. dollar. The Fund may or may not hedge currency risk.

#### Hedging Risk
Hedging transactions seeking to reduce risks may result in poorer overall performance than if the Fund had not engaged in such hedging transactions. Additionally, such transactions may not fully hedge the Fund's risks.

#### Reinvestment Risk
CLOs will typically generate cash from asset repayments and sales that may be reinvested in substitute assets, subject to compliance with applicable investment tests. If the CLO collateral manager causes the CLO to purchase substitute assets at a lower yield than those initially acquired or sale proceeds are maintained temporarily in cash, it would reduce the excess interest-related cash flow, thereby having a negative effect on the fair value of the Fund's assets and the market value of the Fund's securities. In addition, the reinvestment period for a CLO may terminate early, which would cause the holders of the CLO's securities to receive principal payments earlier than anticipated. There can be no assurance that the Fund will be able to reinvest such amounts in an alternative investment that provides a comparable return relative to the credit risk assumed.

#### Interest Rate Risk
The price of certain of the Fund's investments may be significantly affected by changes in interest rates, including increases and decreases in interest rates caused by governmental actions and/or other factors. Although senior secured loans are generally floating rate instruments, the Fund's investments in senior secured loans through investments in junior equity and debt tranches of CLOs are sensitive to interest rate levels and volatility. For example, because the senior secured loans constituting the underlying collateral of CLOs typically pay a floating rate of interest, a reduction in interest rates would generally result in a reduction in the residual payments made to

31 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

the Fund as a CLO equity holder (as well as the cash flow the Fund receives on the Fund's CLO debt investments and other floating rate investments). Further, there may be some difference between the timing of interest rate resets on the assets and liabilities of a CLO. Such a mismatch in timing could have a negative effect on the amount of funds distributed to CLO equity investors. In addition, CLOs may not be able to enter into hedge agreements, even if it may otherwise be in the best interests of the CLO to hedge such interest rate risk. Furthermore, in the event of a significant rising interest rate environment and/or economic downturn, loan defaults may increase and result in credit losses that may adversely affect the Fund's cash flow, fair value of the Fund's assets and operating results. Because CLOs generally issue debt on a floating rate basis, an increase in the relevant reference rate will increase the financing costs of CLOs.

#### Refinancing Risk
If the Fund incurs debt financing and subsequently refinances such debt, the replacement debt may be at a higher cost and on less favorable terms and conditions. If the Fund fails to extend, refinance or replace such debt financings prior to their maturity on commercially reasonable terms, the Fund's liquidity will be lower than it would have been with the benefit of such financings, which would limit the Fund's ability to grow, and holders of the Fund's common shares would not benefit from the potential for increased returns on equity that incurring leverage creates.

#### Tax Risk
If the Fund fails to qualify for tax treatment as a RIC under Subchapter M of the Code for any reason, or otherwise becomes subject to corporate income tax, the resulting corporate taxes (and any related penalties) could substantially reduce the Fund's net assets, the amount of income available for distributions to the Fund's common shareholders, and the amount of income available for payment of the Fund's other liabilities.

#### Derivatives Risk
Derivative instruments in which the Fund may invest may be volatile and involve various risks different from, and in certain cases greater than, the risks presented by other instruments. The primary risks related to derivative transactions include counterparty, correlation, liquidity, leverage, volatility, over-the-counter trading, operational and legal risks. In addition, a small investment in derivatives could have a large potential impact on the Fund's performance, effecting a form of investment leverage on the Fund's portfolio. In certain types of derivative transactions, the Fund could lose the entire amount of the Fund's investment; in other types of derivative transactions the potential loss is theoretically unlimited.

#### Counterparty Risk
The Fund may be exposed to counterparty risk, which could make it difficult for the Fund or the issuers in which the Fund invests to collect on obligations, thereby resulting in potentially significant losses.

#### Price Risk
Investors who buy common shares at different times will likely pay different prices.

#### Non-U.S. Investing Risk
Investing in foreign entities or issuers with underlying non-U.S. assets may expose us to additional risks not typically associated with investing in U.S. entities and issuers. These risks include changes in exchange control regulations, political and social instability, restrictions on the types or amounts of investment, the imposition of sanctions, tariffs, or other governmental restrictions, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the U.S., higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual

32 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

obligations, lack of uniform accounting and auditing standards, currency fluctuations and greater price volatility. Further, we, and the issuers in which we invest, may have difficulty enforcing creditor's rights in foreign jurisdictions.

#### Global Risk
Due to highly interconnected global economies and financial markets, the value of the Fund's securities and its underlying investments may go up or down in response to governmental actions and/or general economic conditions throughout the world. Events such as war, military conflict, acts of terrorism, social unrest, natural disasters, recessions, inflation, rapid interest rate changes, supply chain disruptions, sanctions, the spread of infectious illness or other public health threats could also significantly impact the Fund and its investments.

#### Banking Risk
The possibility of future bank failures poses risks of reduced financial market liquidity at clearing, cash management and other custodial financial institutions. The failure of banks which hold cash on behalf of the Fund, the Fund's underlying obligors, the collateral managers of the CLOs in which the Fund invests (or managers of other securitized or pooled vehicles in which the Fund invests), or the Fund's service providers could adversely affect the Fund's ability to pursue its investment strategies and objectives. For example, if an underlying obligor has a commercial relationship with a bank that has failed or is otherwise distressed, such obligor may experience delays or other disruptions in meeting its obligations and consummating business transactions. Additionally, if a collateral manager has a commercial relationship with a distressed bank, the manager may experience issues conducting its operations or consummating transactions on behalf of the CLOs it manages, which could negatively affect the performance of such CLOs (and, therefore, the performance of the Fund).

#### Illiquid Shares Risk
The Fund's common shares are not publicly traded and the Fund does not expect a secondary market in the common shares to develop in the foreseeable future, if ever. To provide common shareholders with limited liquidity, the Fund intends to offer to repurchase common shares from common shareholders in each quarter in an amount up to 5% of the Fund's NAV, calculated as of the prior calendar quarter end. The Board has discretion to determine whether the Fund will engage in any common share repurchase, and if so, the terms of such repurchase. An investment in the Fund is not suitable for investors that require short-term liquidity.

4. <br>

#### RELATED PARTY TRANSACTIONS

#### Investment Advisory Agreement
Effective February 11, 2022, the Fund entered into an investment advisory agreement with the Adviser (the "Advisory Agreement"). Pursuant to the terms of the Advisory Agreement, the Fund will pay the Adviser a management fee and an incentive fee for its services.

#### Management fee
The management fee is calculated monthly and payable quarterly in arrears at an annual rate of 1.75% of the Fund's "Managed Assets", provided, that, if the Fund calculates its NAV more frequently than monthly, the management fee shall be calculated on the same frequency as the NAV is calculated. Managed Assets are defined as the Fund's total assets (including assets attributable to the Fund's use of leverage) minus the sum of the Fund's accrued liabilities (other than liabilities incurred for the purpose of creating leverage). The Fund was charged a management fee of $1.5 million for the six months ended June 30, 2025, and has a payable balance of $0.8 million as of June 30, 2025.

#### Incentive fee
The incentive fee is payable quarterly, in arrears, on the pre-incentive fee net investment income ("PNII") for the immediately preceding quarter. For this purpose, PNII means (a) interest income, dividend income and any other

33 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

income (including any other fees, such as commitment, origination, structuring, diligence and consulting fees) accrued during the calendar quarter, minus (b) the Fund's operating expenses for the quarter (including the management fee, expenses payable under the Administration Agreement (as defined below) to the Administrator, and any interest expense and/or dividends paid on any issued and outstanding debt or preferred shares, but excluding organizational and offering expenses and the incentive fee) after giving application to any reimbursement or recoupment under the ELA (as defined below). PNII includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments payment-in-kind interest and zero coupon securities), accrued income that the Fund has not yet received in cash. PNII does not include any realized or unrealized capital gains or losses.

PNII, expressed as a rate of return on the value of the Fund's net assets at the end of the immediately preceding calendar quarter, is compared to a hurdle rate of 2.00% per quarter. The Fund pays the Adviser an incentive fee with respect to the Fund's PNII in each calendar quarter as follows: (1) no incentive fee in any calendar quarter in which the Fund's PNII does not exceed the hurdle rate of 2.00%; (2) 100% of the Fund's PNII with respect to that portion of such PNII, if any, exceeding the hurdle rate but equal to or less than 2.50% in any calendar quarter; and (3) 20% of the amount of the Fund's PNII, if any, exceeding 2.50% in any calendar quarter. The Fund incurred incentive fees of $1.2 million for the six months ended June 30, 2025, and has a payable balance of $0.6 million as of June 30, 2025.

#### Administration Agreement
Effective February 11, 2022, the Fund entered into an administration agreement (the "Administration Agreement") with the Administrator, an affiliate of the Adviser. Pursuant to the Administration Agreement, the Administrator performs, or arranges for the performance of, the Fund's required administrative services, which include being responsible for the financial records which the Fund is required to maintain and preparing reports which are disseminated to the Fund's shareholders. In addition, the Administrator provides the Fund with accounting services, assists the Fund in determining and publishing its NAV, oversees the preparation and filing of the Fund's tax returns, monitors the Fund's compliance with tax laws and regulations, and prepares and assists the Fund with any audit of the financial statements by an independent public accounting firm. The Administrator is also responsible for managing the printing and disseminating reports to the Fund's shareholders and maintaining the Fund's website, providing support to investor relations, generally overseeing the payment of the Fund's expenses and the performance of administrative and professional services rendered to the Fund by others, and providing such other administrative services as the Fund may designate from time to time.

Payments under the Administration Agreement are equal to an amount based upon the Fund's allocable portion of the Administrator's overhead in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions and the Fund's allocable portion of the compensation of the Fund's chief compliance officer, chief financial officer, chief operating officer and the Fund's allocable portion of the compensation of any related support staff. The Fund's allocable portion of such compensation is based on an allocation of the time spent on the Fund relative to other matters. To the extent the Administrator outsources any of its functions, the Fund pays the fees on a direct basis, without profit to the Administrator. Certain accounting and other administrative services have been delegated by the Administrator to ALPS Fund Services, Inc. (the "Sub Administrator"). The Administration Agreement may be terminated by the Fund without penalty upon not less than sixty days' written notice to the Administrator and by the Administrator upon not less than ninety days' written notice to the Fund. The Administration Agreement is approved by the Board on an annual basis.

For the six months ended June 30, 2025, the Fund was charged a total of $0.2 million in administration fees consisting of $0.2 million and $0.1 million, relating to services provided by the Administrator and Sub

34 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

Administrator, respectively, which are included in the Consolidated Statement of Operations and, of which $0.1 million was payable as of June 30, 2025.

#### Expense Limitation and Reimbursement Agreement
On February 11, 2022, the Fund and the Adviser entered into an expense limitation and reimbursement agreement, which was amended and restated on February 13, 2024 and July 30, 2024 (the "ELA"). Pursuant to the ELA, the Adviser may provide expense support by paying, directly or indirectly, the Fund's operating expenses or waive fees due by the Fund to the Adviser or affiliates of the Adviser to the extent deems appropriate in the effort to limit expenses borne by the Fund. Expense support payments or fee waivers made by the Adviser may be subject to reimbursement from the Fund for up to three years after such expense support payment or waiver was made. Reimbursement to the Adviser must be approved by the Board prior to recoupment by the Adviser. The Adviser did not provide expense support for the six months ended June 30, 2025.

The following amounts are subject to reimbursement by the Adviser by the following dates:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Period Ended**  | **Expense Support <br> Payments <br> From Adviser**  | **Expense Support <br> Payments Reimbursed <br> to Adviser**  | **Expense Support <br> Waived by Adviser**  | **Unreimbursed <br> Expense Support**  | **Eligible to be <br> Paid Through**  |
| June 30, 2022  | $14094 | $&nbsp;&nbsp;&nbsp;&nbsp;— | $14094 | $— | June 30, 2025  |
| September 30, 2022  | 53891 |  |  | 53891 | September 30, 2025  |
| December 31, 2022  | 172748 |  |  | 172748 | December 31, 2025  |
| March 31, 2023  | 181991 |  |  | 181991 | March 31, 2026  |
| June 30, 2023  | 205617 |  |  | 205617 | June 30, 2026  |
| September 30, 2023  | 413782 |  |  | 413782 | September 30, 2026  |
| December 31, 2023  | 623430 |  |  | 623430 | December 31, 2026  |
| Total  | $1665553 | $— | $14094 | $1651460 |  |

---

#### Organizational and Offering Expense Support and Reimbursement Agreement
On February 11, 2022, the Fund and the Adviser entered into an organizational and offering ("O&O") expense support and reimbursement agreement, which was amended and restated on February 13, 2024 ("O&O Agreement"). Pursuant to the O&O Agreement, the Fund may pay O&O expenses up to a limit of 1.50% of gross proceeds raised in the Fund's offering of its shares. As of December 31, 2024, the Fund had $0.5 million in O&O expenses capitalized as a deferred asset in the Consolidated Statement of Assets and Liabilities. For the six months ended June 30, 2025, the Fund incurred and capitalized additional offering expenses of $0.2 million, and amortized to expense on the Consolidated Statement of Operations $0.5 million of capitalized offering expenses. In addition to offering expenses incurred by the Fund, the Adviser, on behalf of the Fund, paid O&O costs of approximately $2.2 million for the period from the Fund's formation on October 22, 2021 to June 30, 2025. O&O expenses paid by the Adviser are subject to reimbursement by the Fund up to three years after the date on which such O&O expenses were paid on the Fund's behalf. Reimbursement must be approved by the Board. As of June 30, 2025, the Adviser has not sought reimbursement for any O&O expenses it incurred.

35 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

The following amounts may be subject to reimbursement by the Adviser by the following dates:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **O&O Expenses <br> Paid by Adviser**  | **O&O Expenses <br> Paid by Adviser**  | **O&O Expenses <br> Waived by <br> Adviser**  | **Unreimbursed <br> O&O Expenses**  | **Unreimbursed <br> O&O Expenses**  | **Eligible to be Paid <br> Through**  |
|  | | $35093 | | | | |
|  | | 560093 | | | | |
|  | | 351412 | | | | |
|  | | 150629 | | | | |
|  | | 227336 | | | | |
|  | | 126179 | | | | |
|  | | 324003 | | | | |
|  | | 116004 | | | | |
|  | | 249796 | | | | |
|  | | 44104 | | | | |
|  | | 57568 | | | | |
|  | | 737 | | | | |
| | &nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp; | 243 | $35093<br>560093<br>351412<br>— | &nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp; | $—<br>150629<br>227336<br>126179<br>324003<br>116004<br>249796<br>44104<br>57568<br>737<br>243 | December 31, 2024 <br>March 31, 2025 <br>June 30, 2025 <br>September 30, 2025 <br>December 31, 2025 <br>March 31, 2026 <br>June 30, 2026 <br>September 30, 2026 <br>December 31, 2026 <br>March 31, 2027 <br>June 30, 2027 <br>September 30, 2027 <br>December 31, 2027  |
| Total  |  | $2243197 | $946598 |  | $1296599 |  |

---

#### Exemptive Relief
The SEC granted exemptive relief to the Adviser and its affiliates which permits the Fund to participate in certain negotiated co-investments alongside other accounts managed by the Adviser, or its affiliates, subject to certain conditions.

#### Affiliated Ownership
As of June 30, 2025, the Adviser and senior investment team held an aggregate of 11.0% of the Fund's common shares and 0.3% of the Series A Term Preferred Shares. This represented 9.9% of the total outstanding voting shares of the Fund as of June 30, 2025.

#### Dealer Manager
On March 1, 2024, the Fund entered into a dealer manager agreement (the "Dealer Manager Agreement") with Eagle Point Securities LLC (the "Dealer Manager"), a registered broker-dealer and an affiliate of the Adviser. Pursuant to the terms of the Dealer Manager Agreement, the Dealer Manager acts as a distributor of the Fund's common shares on a best-efforts basis, subject to various conditions. Common shares are offered for sale through the Dealer Manager at NAV plus any applicable sales load. Under the Dealer Manager Agreement, the Dealer Manager also provides certain marketing and wholesale services in consideration of receipt of a dealer manager fee.

Common shareholders purchasing the Fund's common shares may pay a sales load of up to 6.75% of the investment amount. The 6.75% sales load is comprised of up to 6.0% selling commission and up to 0.75% dealer manager fee. For the six months ended June 30, 2025, the total amount of sales loads earned by the Dealer Manager was $1.3 million. The Dealer Manager may reallow a portion or all of the earned selling commissions and/or the dealer manager fees to participating broker-dealers and/or financial advisors for selling shares to their customers.

In addition, the Fund may reimburse the Adviser and its affiliates (including the Dealer Manager) for compensation of employees engaged in registering and marketing the Fund's common shares, which includes

36 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

development of the Fund's marketing materials and marketing presentations, training and education, and general coordination of the marketing process for the Fund. For the six months ended June 30, 2025, the Fund has reimbursed the Dealer Manager $0.3 million for such expenses, which is included in deferred offering costs attributed to common shares in the Consolidated Statement of Assets and Liabilities.

5. <br>

#### SHAREHOLDERS' EQUITY
The Fund offers its common shares on a continuous basis at the applicable period end NAV per share plus any applicable sales load. The Fund is authorized to issue an unlimited number of common shares.

For the six months ended June 30, 2025, the Fund sold 3,387,206 common shares for total net proceeds to the Fund of $29.6 million.

For the six months ended June 30, 2025, the Fund issued 292,946 common shares pursuant to the Fund's distribution reinvestment plan for total net proceeds to the Fund of $2.4 million.

As of June 30, 2025, the Fund had 14,295,539 common shares issued and outstanding.

#### Repurchases of Common Shares by the Fund
Subject to the Board's discretion, the Fund conducts quarterly tender offers in accordance with the Fund's common share repurchase program in an amount up to 5% of the Fund's NAV. The Fund may extend multiple offers to repurchase common shares in a quarter in an aggregate amount of 5% of the Fund's NAV.

The following table summarizes the number of common shares that were repurchased by the Fund for the six months ended June 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Commencement Date**  | **Valuation Date**  | **Acceptance <br> Date**  | **Repurchase <br> Price per <br> Share**  | **Shares <br> Repurchased**  | **Total Paid for <br> Repurchased <br> Shares <br> (in millions)**  |
| November 29, 2024  | December 30, 2024  | January 22, 2025  | $9.62 | 336516 | $3.2 |
| February 28, 2025  | March 31, 2025  | April 17, 2025  | 8.28 | 93864 | 0.8 |
|  |  |  |  | 430380 | $4.0 |

---

6. <br>

#### COMMITMENTS AND CONTINGENCIES
The Fund is not currently subject to any material legal proceedings. From time to time, the Fund may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of the Fund's rights under contracts. While the outcome of these legal proceedings cannot be predicted with certainty, the Fund does not expect these proceedings will have a material effect upon its financial condition or results of operations.

As of June 30, 2025, the Fund has received support from the Adviser pursuant to the O&O Agreement and ELA which may be subject to reimbursement in the future. See Note 4 "Related Party Transactions" for further details. The Fund had no other unfunded commitments as of June 30, 2025.

7. <br>

#### INDEMNIFICATIONS
Under the Fund's organizational documents, its officers and trustees are indemnified against certain liabilities arising out of the performance of their duties to the Fund. In addition, during the normal course of business, the

37 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

Fund enters into contracts containing a variety of representations which provide general indemnifications. The Fund's maximum exposure under these agreements cannot be known; however, the Fund expects any risk of loss to be remote.

8. <br>

#### REVOLVING CREDIT FACILITY
On June 28, 2024 the Fund entered into a credit agreement, which was amended on June 25, 2025 with BNP Paribas, as lender, that established a revolving credit facility (the "Revolving Credit Facility"). Pursuant to the terms of the Revolving Credit Facility, the Fund can borrow up to an aggregate principal balance of $25.0 million (the "Commitment Amount"). The Revolving Credit facility is collateralized by certain investments held by the Fund. The Fund has granted a security interest in certain assets to BNP Paribas, as lender. Such borrowings under the Revolving Credit Facility bear interest at Term SOFR plus a spread. The Fund is required to pay a commitment fee on the unused amount.

The Revolving Credit Facility will mature on the earlier of (i) the termination of the Commitment, as defined by the terms of the Revolving Credit Facility or (ii) the scheduled maturity date of June 28, 2026. The Fund has the option to extend the maturity from time to time in accordance with the Revolving Credit Facility agreement.

For the six months ended June 30, 2025, the Fund had an average outstanding borrowing and average interest rate of approximately $10.0 million and 6.69%, respectively. The interest expense for the six months ended June 30, 2025 on the Revolving Credit Facility was approximately $0.5 million, inclusive of the unused fee and amortization of deferred financing costs, and is recorded on the Consolidated Statement of Operations. As of June 30, 2025, the Fund had no outstanding borrowings.

See Note 10 "Asset Coverage" for further discussion on the Fund's calculation of asset coverage with respect to the Revolving Credit Facility.

9. <br>

#### MANDATORILY REDEEMABLE PREFERRED SHARES
As of June 30, 2025, the following Preferred Shares were issued and outstanding.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Security**  | **Maturity<sup>(1)</sup>**  | **Callable<sup>(2)</sup>**  | **Shares <br> Outstanding**  | **Shares <br> Authorized**  | **Liquidation <br> Preference**  |
|  Series A Term Preferred Shares  | October 31, 2029  | October 19, 2026  | 1400000 | 1426000 | $35000000 |
|  Series B Term Preferred Shares  | April 3, 2030  | April 2, 2027  | 300000 | Unlimited | 30000000 |
|  |  |  |  |  | $65000000 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(1)</sup> <br>

The date which the Fund is required to redeem all outstanding shares of the Preferred Shares, at a redemption price of $25 per share and $100 per share for Series A Term Preferred Shares and Series B Term Preferred Shares, respectively, plus accumulated but unpaid dividends, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(2)</sup> <br>

The date which the Fund may, at its sole option, redeem the outstanding shares of the Preferred Shares in whole or in part from time to time.

The Fund has accounted for its Preferred Shares as a liability under ASC Topic 480 — Distinguishing Liabilities from Equity ("ASC 480"), due to their mandatory redemption requirements.

On April 3, 2025, the Fund closed an underwritten private placement offering of 300,000 of the Series B Term Preferred Shares, resulting in net proceeds to the fund of $29.1 million after payment of commissions of $0.9 million.

38 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

The Fund may in the future engage a broker-dealer to repurchase opportunistically, on the Fund's behalf, shares of the Preferred Shares through open market transactions. The price and other terms of any such repurchases will depend on prevailing market conditions, the Fund's liquidity and other factors. Depending on market conditions, the amount of Preferred Shares repurchases may be material and may continue through year-end 2025; however, the Fund may reduce or extend this time frame in its discretion and without notice. Any Preferred Shares repurchases will comply with the provisions of the 1940 Act and the Securities Exchange Act of 1934. The repurchase of any such Preferred Shares would reduce the Fund's outstanding leverage. The Fund did not repurchase Preferred Shares for the six months ended June 30, 2025.

Except where otherwise stated in the 1940 Act or the Fund's declaration of trust, each holder of Preferred Shares will be entitled to one vote for each Preferred Share held on each matter submitted to a vote of the Fund's shareholders. The Fund's preferred shareholders and common shareholders will vote together as a single class on all matters submitted to the Fund's shareholders. Additionally, the Fund's preferred shareholders will have the right to elect two Preferred Trustees at all times, while the Fund's preferred shareholders and common shareholders, voting together as a single class, will elect the remaining members of the Board.

10. <br>

#### ASSET COVERAGE
Under the provisions of the 1940 Act, the Fund is permitted to issue senior securities, including debt securities and preferred shares, and borrow from banks or other financial institutions, provided that the Fund satisfies certain asset coverage requirements.

With respect to senior securities that are shares, such as the Preferred Shares, the Fund is required to have asset coverage of at least 200%, as measured at the time of issuance of any such senior securities that are shares and calculated as the ratio of the Fund's total consolidated assets, less all liabilities and indebtedness not represented by senior securities, over the aggregate amount of the Fund's outstanding senior securities representing indebtedness plus the aggregate liquidation preference of any outstanding shares of senior securities that are shares.

With respect to senior securities representing indebtedness, such as any bank borrowings (other than temporary borrowings as defined under the 1940 Act), the Fund is required to have asset coverage of at least 300%, as measured at the time of borrowing and calculated as the ratio of the Fund's total consolidated assets, less all liabilities and indebtedness not represented by senior securities, over the aggregate amount of the Fund's outstanding senior securities representing indebtedness.

If the Fund's asset coverage declines below 300% (or 200%, as applicable), the Fund would be prohibited under the 1940 Act from incurring additional debt or issuing additional Preferred Shares and from declaring certain distributions to its shareholders. In addition, the terms of the Preferred Shares require the Fund to redeem Preferred Shares if such failure to maintain the applicable asset coverage is not cured by a certain date.

39 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries<br>**Notes to Consolidated Financial Statements**<br>June 30, 2025 <br>(Unaudited)

The following table summarizes the Fund's asset coverage with respect to its Preferred Shares and Revolving Credit Facility as of June 30, 2025, and as of December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **As of <br> June 30, 2025**  | **As of <br> December 31, 2024**  |
| Total assets  | $188829191 | $162913657 |
| Less liabilities and indebtedness not represented by senior securities  | (3648152) | (3959395) |
| Net total assets and liabilities  | $185181039 | $158954262 |
| Preferred Shares<sup>(3)</sup>  | $65000000 | $35000000 |
| Revolving Credit Facility<sup>(3)</sup>  |  | 19500000 |
| Total senior securities  | $65000000 | $54500000 |
| Asset coverage for senior securities<sup>(1)</sup>  | 285% | 292% |
| Asset coverage for Revolving Credit Facility<sup>(2)(3)</sup>  | N/A | 815% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(1)</sup> <br>

The asset coverage for senior securities is calculated in accordance with section 18(h) of the 1940 Act, as generally described above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(2)</sup> <br>

The asset coverage ratio for the Revolving Credit Facility is calculated in accordance with section 18(h) of the 1940 Act, as generally described above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(3)</sup> <br>

Amounts are based on outstanding principal balance as of the date presented.

11. <br>

#### SUBSEQUENT EVENTS
Pursuant to the continuous offering, in the period from July 1, 2025 through July 31, 2025, the Fund issued 697,275 common shares for total net proceeds to the Fund of $6.0 million. On July 21, 2025, the Fund accepted and paid $1.4 million related to the repurchase of 161,487 common shares in accordance with the tender offer that commenced May 30, 2025.

On July 31, 2025, the Fund paid a distribution of $0.083 per share to common shareholders of record as of July 22, 2025.

The Fund's NAV per share as of July 31, 2025 was $8.85.

Management of the Fund has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date of release of this report. Management has determined there are no events in addition to those described above which would require adjustment to or disclosure in the consolidated financial statements and related notes through the date of release of this report.

40 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Financial Highlights** <br>(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Per Share Data:**  | **For the six months <br> ended June 30, 2025**  | **For the year ended <br> December 31, 2024**  | **For the year ended <br> December 31, 2023**  | **For the period from <br> June 1, 2022 <br> (Commencement of <br> Operations) through <br> December 31, 2022**  |
| Net asset value at beginning of period  | $9.62 | $10.23 | $9.97 | $10.00 |
| Net investment income<sup>(1)</sup>  | 0.36 | 0.89 | 1.40 | 0.52 |
|  Net realized gain (loss) and change in unrealized appreciation (depreciation) on <br> investments<sup>(1)(2)</sup>  | (0.93) | (0.52) | (0.23) | (0.08) |
|  Net income (loss) and net increase (decrease) in net assets resulting from operations<sup>(1)</sup>  | (0.57) | 0.37 | 1.17 | 0.44 |
| Distributions to shareholders from net investment income<sup>(3)</sup>  | (0.50) | (0.98) | (0.91) | (0.08) |
| Distributions to shareholders from net realized gains on investments<sup>(3)</sup>  |  |  |  |  |
| Distributions to shareholders from tax return of capital<sup>(3)</sup>  |  |  |  | (0.38) |
| Total distributions declared to shareholders  | (0.50) | (0.98) | (0.91) | (0.46) |
| Distributions to shareholders based on weighted average shares impact<sup>(4)</sup>  | 0.00 | (0.00) | (0.00) | (0.01) |
| Total distributions to shareholders  | (0.50) | (0.98) | (0.91) | (0.47) |
| Net asset value at end of period  | $8.55 | $9.62 | $10.23 | $9.97 |
| Total net asset value return<sup>(5)</sup>  | (5.7)% | 4.02% | 12.35% | 4.30% |
| Common shares outstanding at end of period  | 14295539 | 11045767 | 4803369 | 1401613 |
| <u>Ratios and Supplemental Data:</u> |  |  |  |  |
| Net asset value at end of period  | $122175957 | $106236316 | $49147210 | $13973898 |
| Ratio of expenses to average net assets, before expense support<sup>(6)(8)</sup>  | 13.39% | 9.43% | 9.93% | 9.62% |
| Ratio of expenses to average net assets, after expense support<sup>(7)(8)</sup>  | 13.39% | 9.43% | 4.54% | 6.35% |
| Ratio of net investment income to average net assets<sup>(7)(8)</sup>  | 8.24% | 8.90% | 13.95% | 10.34% |
| Portfolio turnover rate<sup>(9)</sup>  | 10.82% | 9.43% | 11.74% | 4.63% |
| Asset coverage for senior securities  | 285% | 292% | N/A | N/A |
| Asset coverage for Revolving Credit Facility  | N/A | 815% | N/A | N/A |
| <u>Revolving Credit Facility:</u> |  |  |  |  |
| Principal amount outstanding at end of period  | $— | $19500000 | $— | $— |
| Asset coverage per $1,000 at end of period<sup>(10)</sup>  | $— | $8152 | $— | $— |

---

See accompanying footnotes to the financial highlights on the following page. <br>

41 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Consolidated Financial Highlights** <br>(Unaudited)

#### Footnotes to the Financial Highlights:
<sup>(1)</sup> <br>

Per share amounts are based on weighted average of shares outstanding for the period. Per share distributions paid to preferred shareholders are reflected in net investment income, and totaled ($0.16) and ($0.07) per common share for the six months ended June 30, 2025 and the year ended December 31, 2024, respectively. The aggregate amount of amortized deferred issuance costs associated with the Preferred Shares are reflected in net investment income, and totaled ($0.05) and ($0.01) per common share for the six months ended June 30, 2025 and the year ended December 31, 2024, respectively.

<sup>(2)</sup> <br>

Net realized gain (loss) and change in unrealized appreciation (depreciation) on investments may include a balancing figure to reconcile to the change in NAV per share at the end of each period. The amount per share may not agree with the change in the aggregate net realized gain (loss) and change in unrealized appreciation (depreciation) on investments for the period because of the timing of issuance of the Fund's shares in relation to fluctuating market values for the portfolio.

<sup>(3)</sup> <br>

The information provided is based on estimates available at each respective period. The Fund's final taxable income and the actual amount required to be distributed will be finally determined when the Fund files its final tax returns and may vary from these estimates.

<sup>(4)</sup> <br>

Represents the difference between the per share amount distributed to shareholders of record and the per share amount distributed based on the weighted average of shares outstanding for the period.

<sup>(5)</sup> <br>

Total return for the six months ended June 30, 2025 and the period from June 1, 2022 to December 31, 2022 are not annualized. Total return is calculated based on a change in NAV per share between the beginning and end of period NAV per share and assumes distributions paid to shareholders during the period were reinvested in accordance with the Fund's distribution reinvestment plan.

<sup>(6)</sup> <br>

Ratios for the six months ended June 30, 2025 and the period from June 1, 2022 to December 31, 2022 are annualized. Ratios for the year ended December 31, 2023 and the period from June 1, 2022 to December 31, 2022 exclude expense limitation provided by the Adviser.

<sup>(7)</sup> <br>

Ratios for the six months ended June 30, 2025 and the period from June 1, 2022 to December 31, 2022 are annualized. Ratios for the year ended December 31, 2023 and the period from June 1, 2022 to December 31, 2022 reflect expense limitation provided by the Adviser.

<sup>(8)</sup> <br>

Ratios for the six months ended June 30, 2025 and the year ended December 31, 2024 include interest expense on the credit facility of 0.93% and 0.57% of average net assets, respectively. Ratios for the six months ended June 30, 2025 and the year ended December 31, 2024 include interest expense on the Series A Term Preferred Shares and Series B Term Preferred Shares of 4.80% and 0.85% of average net assets, respectively.

<sup>(9)</sup> <br>

The portfolio turnover rate is calculated as the lesser of total investment purchases executed during the period or the total investment sales executed during the period and repayments of principal, divided by the average fair value of investments for the same period.

<sup>(10)</sup> <br>

The asset coverage per unit figure is the ratio of the Fund's total assets, less liabilities and indebtedness not represented by the credit facility, to the aggregate dollar amount of outstanding borrowings of the credit facility, in accordance with section 18(h) of the 1940 Act. The asset coverage per unit figure is expressed in terms of dollar amounts per $1,000 principal amount.

42 <br>

------

Eagle Point Institutional Income Fund & Subsidiaries <br>**Supplemental Information** 

#### Senior Securities Table
Information about the Fund's senior securities shown in the following table has been derived from the Fund's consolidated financial statements as of and for the dates noted.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Type of Security**  | **Total Amount <br> Outstanding**  | **Asset Coverage <br> Per Unit<sup>(1)</sup>**  | **Involuntary Liquidating <br> Preference Per Unit<sup>(2)</sup>**  | **Average Market <br> Value Per Unit<sup>(3)</sup>**  |
| **For the six months ended June 30, 2025** | **For the six months ended June 30, 2025** |  |  |  |
| Series A Term Preferred Shares | $35000000 | $71.22 | $25.00 | $24.87 |
| Series B Term Preferred Shares | $30000000 | $284.89 | $100.00 | $100.00 |
| Revolving Credit Facility (Texas Capital Bank)  | $0 | NM  | N/A  | N/A  |
| **For the year ended December 31, 2024** | **For the year ended December 31, 2024** |  |  |  |
| Series A Term Preferred Shares | $35000000 | $72.91 | $25.00 | $24.97 |
| Revolving Credit Facility (Texas Capital Bank)  | $19500000 | $8151.50 | N/A  | N/A  |

---

<sup>(1)</sup> <br>

The asset coverage per unit figure is the ratio of the Fund's total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate dollar amount of senior securities, as calculated separately for each of the Preferred Shares and Revolving Credit Facility in accordance with section 18(h) of the 1940 Act. With respect to the Preferred Shares, the asset coverage per unit figure is expressed in terms of dollar amounts per preferred share outstanding (based on a per share liquidation preference of $25 and $100 for the Series A Term Preferred Shares and Series B Term Preferred Shares, respectively). With respect to the Revolving Credit Facility, the asset coverage per unit figure is expressed in terms of dollar amounts per $1,000 of indebtedness.

<sup>(2)</sup> <br>

The involuntary liquidating preference per unit is the amount to which a Preferred Share would be entitled in preference to any security junior to it upon our involuntary liquidation.

<sup>(3)</sup> <br>

The average market value per unit is calculated by taking the average of the closing price (or $100 principal value for unlisted securities) for each of the Preferred Shares (NYSE: EIIA; Unlisted: Series B Preferred Shares). A $100 market value was assumed for unlisted securities.

43 <br>

------

Distribution Reinvestment Plan

Subject to our discretion and applicable legal restrictions, we intend to authorize and declare ordinary cash distributions on a quarterly basis and pay such distributions on a monthly basis. We have adopted an "opt in" distribution reinvestment plan ("DRIP") pursuant to which shareholders may elect to have the full amount of their cash distributions reinvested in additional Shares. Shares will be issued pursuant to the DRIP at a price equal to 95% of their most recently determined net asset value as of the payment date (generally the last business day of each calendar month). There is no sales load or other charge for distributions reinvestment. A request must be received by the Fund before the record date to be effective for that dividend or capital gain distribution. Participants in our DRIP are free to elect or revoke reinstatement in the DRIP within a reasonable time as specified in the plan. If shareholders elect to participate in the DRIP, distributions on Shares are automatically reinvested in additional Shares by one or more affiliates of SS&C Technologies Holdings, Inc. (collectively, "SS&C"), or the "DRIP Agent." Holders of our Shares who receive distributions in the form of additional Shares are nonetheless required to pay applicable federal, state or local taxes on the reinvested distribution and will not receive a corresponding cash distribution with which to pay any applicable tax. Reinvested distributions increase our Shareholders' equity on which a management fee is payable to the Adviser.

We and the DRIP Agent reserve the right to amend or terminate the DRIP upon written notice to each participant at least 30 days before the record date for the payment of any dividend or distribution by us.

All correspondence or additional information about the DRIP should be directed to SS&C, at (833) 360-5520 or by mail: 80 Lamberton Rd, Windsor, Connecticut 06095.

44 <br>

------

Additional Information

Shareholder Meeting Information

At the annual meeting of shareholders of the Fund held on May 23, 2025, and adjourned to July 7, 2025, the shareholders of the Company voted to elect two Class I trustees, with each trustee to serve until the Company's 2028 annual meeting of shareholders or until his successor is duly elected and qualifies. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Nominee**  | **Shares Voted "For"**  | **Shares "Withheld"**  | **Broker Non-Votes**  |
| Scott W. Appleby<sup>(1)</sup>  | 6758963 | 545358 | 0 |
| Jeffrey L. Weiss<sup>(1)</sup>  | 6752020 | 552301 | 0 |

---

<sup>(1)</sup> <br>

Elected by the holders of the Fund's outstanding common shares of beneficial interest and the Fund's outstanding preferred shares of beneficial interest, voting together as a single class.

The following individuals' terms of office as trustees continued after the annual meeting given that each person was not up for election at the annual meeting: Kevin F. McDonald, Paul E. Tramontano, Thomas P. Majewski and James R. Matthews.

Investment Advisory Agreement

At a meeting held on May 23, 2025, the Board of Trustees (the "Board") of Eagle Point Institutional Income Fund (the "Fund"), including all of the trustees that are not interested persons of the Fund (voting separately), unanimously voted to approve the continuation and renewal of the existing investment advisory agreement (the "Investment Advisory Agreement") by and between the Fund and Eagle Point Credit Management LLC (the "Adviser") for an additional one-year period.

In reaching a decision to approve the continuation and renewal of the Investment Advisory Agreement, the Board, assisted by the advice of fund counsel, requested and received a significant amount of information and considered all the factors the Board believed relevant, including, among other things, the following: (1) the nature, extent and quality of services performed by the Adviser, including the investment performance of the Fund, other comparable registered investment companies and certain other accounts advised by the Adviser; (2) information regarding the fees and other expenses paid by the Fund, including the cost of services provided by the Adviser and its affiliates; (3) the profitability to the Adviser of its relationship with the Fund, including certain ancillary and other benefits received by the Adviser; (4) comparative information on fees and expenses borne by other comparable registered investment companies, and certain other funds and accounts advised by the Adviser; (5) the extent to which economies of scale would be realized as the Fund grows and whether fee levels reflect these economies of scale for the benefit of the Fund's investors; and (6) various other factors.

The Board's decision to renew the Investment Advisory Agreement was not based on any single factor, but rather was based on a comprehensive consideration of the information provided to the Board at its meetings throughout the year. The Board did not assign relative weights to the factors considered by it as the Board conducted an overall analysis of these factors. Individual members of the Board may have given different weights to different factors.

The Board requested, considered and evaluated information regarding the following factors, among others:

#### Nature, Extent and Quality of Services and Performance
The Board reviewed and considered the nature, extent and quality of the services provided by the Adviser under the Investment Advisory Agreement. Among other things, the Board reviewed the most recent Form ADV for the Adviser and information about the background and experience of the key personnel of the Adviser primarily responsible for the day-to-day portfolio management of the Fund, including their experience in managing portfolios of CLO securities and the CLO industry knowledge of the Adviser's senior investment team.

The Board also evaluated the ability of the Adviser to attract and retain high-caliber personnel. In this regard, the Board considered information regarding the Adviser's compensation program, which is designed to provide both

45 <br>

------

annual and long-term incentives for its personnel and to align personnel interests with the long-term success of the Adviser's clients, including the Fund.

In addition, the Board reviewed information about the Adviser's investment process, financial stability, investment and risk management programs, the legal and compliance programs of the Adviser, and the Fund's use of leverage, the forms of leverage used by the Fund, the effect of such leverage on the Fund's portfolio and performance and the Adviser's profitability, and the levels of leverage used by three non-listed closed-end investment companies that have an investment strategy comparable to that of the Fund ("Peer Group Funds").

The Board then reviewed and considered the Fund's performance in terms of total return on a net asset value basis during the 1- and 2-year periods ended December 31, 2024, and considered such performance in light of the Fund's investment objective, strategies and risks.

The Board also considered and discussed the Fund's performance in comparison to the performance for various relevant periods of (1) the Peer Group Funds, (2) non-listed registered closed-end investment companies managed by third-party investment advisers that have a portion of their assets invested in the types of securities in which the Fund primarily invests (the "Peer Universe Funds" and together with the Peer Group Funds, the "Peer Funds"), (3) funds and accounts managed by the Adviser and its affiliates that invest a majority of their assets in the types of securities in which the Fund primarily invests (collectively, the "Other Comparable Funds and Account"), and (4) a composite of estimates of CLO equity performance published by several Wall Street research firms. The Board also discussed and considered the Fund's recent performance in light of recent and current market conditions.

Based on the above factors, together with those referenced below, the Board concluded that it was satisfied with, and that the Fund should continue to benefit from, the nature, extent and quality of services provided to the Fund by the Adviser.

#### Investment Advisory Fee Rates and Total Expense Ratio
The Board then reviewed and considered the advisory fee rates, including the base management fee and incentive fee, payable by the Fund to the Adviser under the Investment Advisory Agreement and the total expense ratio of the Fund and any voluntary waivers thereof by the Adviser during the 2024 calendar year. Additionally, the Board received and considered information comparing the advisory fee rates and total expense ratio of the Fund with those of the Peer Funds and certain of the Other Comparable Funds and Account (the "Comparable Expense Funds").

The Board noted that the Fund's contractual management fee rate was higher than that of three of the Peer Funds, lower than that of two of the Peer Funds and lower than the average contractual management fee rate of the Peer Group Funds. The Board noted that the Fund's effective incentive fee rate was higher than three of the Peer Funds and lower than one of the Peer Funds. The Board further considered that the Fund's net expense ratio was higher than that of the average net expense ratio of the Peer Funds. Among other things, the Board considered the differences between the investment strategy of the Fund and the strategy of each of the Peer Funds.

The Board also compared the advisory fee rates paid by each of the Fund and the Peer Funds and the Other Comparable Funds and Account. The Board noted the differences in the fee structures among the Fund on one hand and the Peer Funds and the Other Comparable Funds and Account on the other, and that such differences could cause the Fund to pay a higher or lower effective advisory fee rate than the Peer Funds and the Other Comparable Funds and Account in certain circumstances. The Board considered that the different rate structures are driven by investor expectations for the different fund structures and strategies, the additional complexity of the Adviser's investment strategy in the regulatory and tax environment applicable to the Fund's portfolio, the assumption of entrepreneurial and other risks by the Adviser in sponsoring and providing ongoing services to the Fund, the Fund's investor base, resources dedicated by the Adviser to manage the Fund's inflows and outflows, and the costs associated with operating as an investment adviser for a registered investment company.

In considering the advisory fee rates, the Board also discussed the Fund's use of leverage, including the Fund's issuance of preferred shares and the Fund's use of a revolving credit facility. The Board noted that while the Adviser believes that the prudent use of leverage is in the best interests of the Fund and its shareholders, the use of leverage has the potential to increase the Adviser's base management fee and incentive fee and therefore creates a conflict of interest.

46 <br>

------

Based on its review, the Board concluded that each of the Fund's advisory fee rates and total expense ratio is fair and reasonable in light of the services provided to the Fund and other factors considered.

#### Profitability
The Board also considered a profitability analysis of the Adviser and its affiliates with respect to the Fund. The Board concluded that, in light of the profitability information presented and other factors considered, the Adviser's profitability was not excessive.

#### Economies of Scale
The Board considered the potential growth of the Fund and information regarding whether the Investment Advisory Agreement reflects economies of scale for the benefit of the Fund's investors. The Board considered that, given (1) the complexity and time required to manage and monitor the types of securities in which the Fund invests, (2) the resource-intensive nature of acquiring and disposing of certain of the Fund's investments in the primary markets (particularly with respect to CLO equity investments), (3) the need to manage continuous inflows raised through the Fund's public offering and to manage the liquidity of the Fund's portfolio in connection with the Fund's intention to provide quarterly tender offers and for general risk management purposes and (4) the limited size of individual transactions, any growth in the Fund's assets would be expected to require and had required additional investment resources, including personnel, and therefore generally would not meaningfully reduce the per unit cost of managing the Fund's portfolio. Based on the foregoing, the Board concluded that the opportunity of the Fund to realize significant economies of scale is limited and the fee structure was appropriate given the Fund's investment objectives and strategies.

#### Other Benefits
The Board considered other benefits to the Adviser and its affiliates derived from their relationship with the Fund. The Board considered the Adviser's representation that these ancillary benefits could not be appropriately valued. The Board also considered that Eagle Point Securities LLC, an affiliate of the Adviser, serves as the dealer manager of the Fund. The Board noted that, as dealer manager, Eagle Point Securities LLC receives a dealer manager fee in connection with sales of the Fund's common shares; however, the Board noted that in certain instances, all or a substantial portion of Eagle Point Securities LLC's compensation is waived or re-allowed to the applicable third-party selling intermediary.

Based on the information reviewed and the discussions detailed above, the Board reached a determination, through the exercise of its business judgment, that the compensation payable to the Adviser pursuant to the Investment Advisory Agreement was fair and reasonable in light of the services provided to the Fund by the Adviser and other factors considered.

Portfolio Information

The Fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The Fund Form N-PORT is available without charge, upon request by calling (844) 810-6501, or from the EDGAR Database on the SEC's website (www.sec.gov).

Proxy Voting Records

The Fund has delegated its proxy voting responsibility to the Adviser. A description of these policies and procedures is available (1) without charge, upon request, by calling toll free (844) 810-6501; and (2) in the Fund's prospectus, which can be found on the SEC's website (www.sec.gov).

Information regarding how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available: (1) without charge, upon request, by calling toll free (844) 810-6501; and (2) in the Fund's Form N-PX filing, which can be found on the SEC's website (www.sec.gov). The Fund also makes this information available on its website at www.EPIIF.com.

47 <br>

------

Privacy Notice

The Fund is committed to protecting your privacy. This privacy notice explains the privacy policies of Eagle Point Institutional Income Fund and its affiliated companies. The terms of this notice apply to both current and former shareholders. The Fund will safeguard, according to strict standards of security and confidentiality, all information it receives about you. With regard to this information, the Fund maintains procedural safeguards that are reasonably designed to comply with federal standards. We have implemented procedures that are designed to restrict access to your personal information to authorized employees of the Fund's investment adviser, Eagle Point Credit Management LLC and its affiliates who need to know your personal information to perform their jobs, and in connection with servicing your account. The Fund's goal is to limit the collection and use of information about you. While we may share your personal information with our affiliates in connection with servicing your account, our affiliates are not permitted to share your information with non-affiliated entities, except as permitted or required by law.

When you purchase shares of the Fund and in the course of providing you with products and services, we and certain of our service providers, such as a transfer agent, may collect personal information about you, such as your name, address, social security number or tax identification number. This information may come from sources such as account applications and other forms, from other written, electronic or verbal correspondence, from your transactions, from your brokerage or financial advisory firm, financial adviser or consultant, and/or information captured on applicable websites.

We do not disclose any personal information provided by you or gathered by us to non-affiliated third parties, except as permitted or required by law or for our everyday business purposes, such as to process transactions or service your account. For example, we may share your personal information in order to send you annual and semiannual reports, proxy statements and other information required by law, and to send you information the Fund believes may be of interest to you. We may disclose your personal information to unaffiliated third-party financial service providers (which may include a custodian, transfer agent, accountant or financial printer) who need to know that information in order to provide services to you or to the Fund. These companies are required to protect your information and use it solely for the purpose for which they received it or as otherwise permitted by law. We may also provide your personal information to your brokerage or financial advisory firm and/or to your financial adviser or consultant, as well as to professional advisors, such as accountants, lawyers and consultants.

We reserve the right to disclose or report personal or account information to non-affiliated third parties in limited circumstances where we believe in good faith that disclosure is required by law, such as in accordance with a court order or at the request of government regulators or law enforcement authorities or to protect our rights or property. We may also disclose your personal information to a non-affiliated third party at your request or if you consent in writing to the disclosure.

If you have any questions or concerns about the privacy of your personal information, please contact our investor relations team at (844) 810-6501.

We will review this policy from time to time and may update it at our discretion.

\* \* \*

48 <br>

------

End of Semiannual Report. Back Cover Follows.

------

![[MISSING IMAGE: cv_obc-4c.jpg]](cv_obc-4c.jpg)

------

**Item 2. Code of Ethics**

The information required by this Item is only required in an annual report on this Form N-CSR.

**Item 3. Audit Committee Financial Expert**

The information required by this Item is only required in an annual report on this Form N-CSR.

**Item 4. Principal Accountant Fees and Services**

The information required by this Item is only required in an annual report on this Form N-CSR.

**Item 5. Audit Committee of Listed Registrant**

The information required by this Item is only required in an annual report on this Form N-CSR.

**Item 6. Investments**

(a) A schedule of investments is included in the registrant's report to shareholders under Item 1.

(b) Not applicable.

**Item 7. Financial Statements and Financial Highlights For Open-End Management Investment Companies**

Not applicable.

**Item 8. Changes in and Disagreements With Accountants For Open-End Management Investment Companies**

Not applicable.

**Item 9. Proxy Disclosures for Open-End Management Investment Companies**

Not applicable.

**Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies**

Not applicable.

**Item 11. Statement Regarding Basis For Approval of Investment Advisory Contract**

Not applicable.

**Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies**

The information required by this Item is only required in an annual report on this Form N-CSR.

**Item 13. Portfolio Managers of Closed-End Investment Companies**

&nbsp;&nbsp;&nbsp;&nbsp;(a) The information required by this Item is only required in an annual report on this Form N-CSR.

&nbsp;&nbsp;&nbsp;&nbsp;(b) There has been no change, as of the date of the filing of this N-CSR, to any of the portfolio managers
identified in response to this item in the Registrant's most recent annual report on Form N-CSR.

**Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchases**

None.

**Item 15. Submission of Matters to a Vote of Security Holders**

None.

**Item 16. Controls and Procedures**

&nbsp;&nbsp;&nbsp;&nbsp;(a) The registrant's principal executive and principal financial officers, or persons performing similar functions, have concluded
that the registrant's disclosure controls and procedures (as defined in Rule 30(a)-3(c) under the Investment Company Act
of 1940, as amended (the "1940 Act")), are effective as of a date within 90 days of the filing of this report, based on the
evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rules 13a-15(b) or 15d-15(b) under
the Exchange Act.

&nbsp;&nbsp;&nbsp;&nbsp;(b) There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under
the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially
affect, the registrant's internal control over financial reporting.

**Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies**

The registrant did not engage in securities lending activity during its most recent fiscal year.

**Item 18. Recovery of Erroneously Awarded Compensation**

Not applicable.

**Item 19. Exhibits**

[(a) (3)](tm2524120d1_ex99-cert.htm) [Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 filed herewith.](tm2524120d1_ex99-cert.htm)

[(b)](tm2524120d1_ex99-906cert.htm) [Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 filed herewith.](tm2524120d1_ex99-906cert.htm)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**EAGLE POINT INSTITUTIONAL INCOME FUND**

---

| | |
|:---|:---|
| By: | /s/ Thomas P. Majewski |
|  | Thomas P. Majewski |
|  | Chief Executive Officer (Principal Executive Officer) |
| Date: | August 27, 2025 |

---

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.

---

| | |
|:---|:---|
| By: | /s/ Thomas P. Majewski |
|  | Thomas P. Majewski |
|  | Chief Executive Officer (Principal Executive Officer) |
| Date: | August 27, 2025 |
| By: | /s/ Alena Umnova |
|  | Alena Umnova |
|  | Chief Financial Officer (Principal Financial Officer) |
| Date: | August 27, 2025 |

---

## Ex-99.Cert

**Exhibit 99.CERT**

**CERTIFICATIONS**

(Section 302)

I, Thomas P. Majewski, Principal Executive Officer of the Registrant, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this report on Form N-CSR of Eagle Point Institutional Income Fund;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required
to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report
based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period
covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control
over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the Audit Committee
of the registrant's board of trustees (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.

Dated: August 27, 2025

---

| | |
|:---|:---|
| By: | /s/ Thomas P. Majewski |
|  | Thomas P. Majewski |
|  | Principal Executive Officer |

---

**CERTIFICATIONS**

(Section 302)

I, Alena Umnova, Principal Financial Officer of the Registrant, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this report on Form N-CSR of Eagle Point Institutional Income Fund;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required
to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report
based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period
covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control
over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the Audit Committee
of the registrant's board of trustees (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.

Dated: August 27, 2025

---

| | |
|:---|:---|
| By: | /s/ Alena Umnova |
|  | Alena Umnova |
|  | Principal Financial Officer |

---

## Exhibit 99.906

**Exhibit 99.906CERT**

**Certification Under Section 906<br> of the Sarbanes-Oxley Act of 2002**

Thomas P. Majewski, Principal Executive Officer, and Alena Umnova, Principal Financial Officer of Eagle Point Institutional Income Fund (the "registrant"), each certify to the best of his or her knowledge that:

&nbsp;&nbsp;&nbsp;&nbsp;1. The registrant's periodic report on Form N-CSR for the six months ended June 30, 2025 (the "Form N-CSR")
fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of
operations of the registrant.

---

| | |
|:---|:---|
| Principal Executive Officer | Principal Financial Officer |
| Eagle Point Institutional Income Fund | Eagle Point Institutional Income Fund |
| /s/ Thomas P. Majewski | /s/ Alena Umnova |
| Thomas P. Majewski | Alena Umnova |
| Date: August 27, 2025 | Date: August 27, 2025 |

---

This certification is being furnished to the Securities and Exchange Commission pursuant to Rule 30a-2(b) under the Investment Company Act of 1940, as amended, and 18 U.S.C. 1350 and is not being filed as part of the Form N-CSR with the Securities and Exchange Commission.